IDI Abstracts

  • Timing And Incidence Of Hiv-Associated Tuberculosis: A 4-Country Study” (Id 2379.

    Enrico Girardi, Yanink Caro-Vega, Jospeh Musaazi, Gabriela Carriquiry, Alessandro Cozzi-Lepri, Barbara Castelnuovo, Andrea Gori, Yukari C. Manabe, Eduardo Gotuzzo, Antonella D'Arminio Monforte, Brenda Crabtree-Ramírez, Cristina Mussini

    2018

  • Call For Life Uganda Tm: An Rct Using Interactive Voice Response For Plhiv On Art” (Id 3031).

    Rosalind M. Parkes-Ratanshi, Maria S. Nabaggala, Agnes N. Bwanika, Mohammed Lamorde, Rachel King, Noela Owarwo, Eva A. Laker Odongpiny, Richard Orama, Barbara Castelnuovo, Agnes Kiragga. Call For Life Uganda Tm

    2018

  • Double-Dose Levonorgestrel Implant Does Not Fully Overcome Interaction With Efavirenz” (Id 2726)

    Kimberly K. Scarsi, Lauren Cirrincione, Shadia Nakalema, Kristin Darin, Ian Musinguzi, Isabella Kyohairwe, Pauline Byakika-Kibwika, Andrew Owen, Lee Winchester, Anthony Podany, Susan E. Cohn, David Back, Courtney V. Fletcher, Marco Siccardi, Mohammed Lamorde

    2018

  • Subclinical Tubular Impairment Is Common In Art-Treated Hiv+ Patients In Uganda” (Id 2191).

    Cecilia Costa, Silvia Scabini, Arvind Kaimal, William Kasozi, Jessica Cusato, Olive Mbabazi, John Bosco Kafufu, Erisa Mwaka, Giovanni Di Perri, Mohammed Lamorde, Andrea Calcagno, Barbara Castelnuovo.

    2018

  • Ugandan Clinic Experience Following Potential Teratogenicity Alert For Dolutegravir” (Id 2969).

    Arinaitwe S. Arnold, Eva A. Laker Odongpiny, Noela Owarwo, Onzia Annet, Nasasira Benson, Wailagala Abdullah, Ivan Kalule, Anguzu Godwin, Agnes Kiragga, Kay Seden, Barbara Castelnuovo, Isaac Lwanga, Rachel Musomba, Mohammed Lamorde

    2018

  • Population Pk Of Dolutegravir In Plasma, Cord, And Breastmilk: Results From Dolphin-1″ (Id 2933).

    Laura Dickinson, Kenneth Kintu, Julie Anne Coombs, Alieu Amara, Christie Heiberg, Stephen I. Walimbwa, Yashna Singh, Shadia Nakalema, Laura Else, Landon Myer, Catriona Waitt, Mohammed Lamorde, Catherine Orrell, Saye Khoo

    2018

  • The Impact Of HIV Exposure On Placental Pathology And Treg Cells” (Id 1916)

    Nadia M. Ikumi1, Nonzwakazi Bangani1, Michelle Barboure1, Berenice Alinde1, Bryan Gascon1, Lizette Fick1, Komala Pillay1, Landon Myer1, Thoko Malaba1, Mohammed Lamorde1, Saye Khoo1, Heather Jaspan1, Clive M. Gray

    2018

  • Presenting Conditions at an urgent care service within a specialist HIV Out patients Clinic in Uganda

    Lumu I, Musaazi J, Owarwo N, Walimbwa SI, Seden K, Lamorde M

    2018

  • The burden of chronic co-morbidities among HIV infected adults in a large Urban HIV Clinic In Uganda.

    Rachel Musomba, Noela Owarwo, Maria Sarah Nabaggala, Mark Nsumba, John Matovu, Mohammed Lamorde, Barbara Castelnuovo

    2018

  • Etiology and Antimicrobial Resistance Patterns of Salmonella Bacteremia in Hospitalized Children with Acute Febrile Illness — Uganda, 2016–2017.

    Alison V. Winstead, A. Mpimbaza, A. Sserwanga, J. Kapisi2, C. Maiteki, M. R. Kamya, M. Lamorde, R. Walwema, F. Kizito, A. Kusemererwa, H. Tasimwa, Y. Manabe, G. Odongo, R. Ransom, J. N. Borchert, M. Mikoleit, P. S. Mead, K. Kugeler, M. Freeman, E. Mintz, Grace D. Appiah

    2018

  • A pilot project to enhance research capacity building through in-house and peer mentorship

    Castelnuovo Barbara, Namwase Angella Sandra, Okoboi Stephen, Kambugu Andrew

    2018

  • Advocates for patient safety in a large HIV outpatient facility: feasibility and impact of a pilot training program in Uganda

    Seden K, Kukundakwe M, Kamoga R, Musomba R, Tindyebwa E, Lwanga I, Lamorde M.

    2018

  • Causal relationship between risky sexual behavior and HIV testing among young adults (18-35 years) in Uganda: a structural equation analysis

    Maria Sarah Nabaggala, Joseph Musaazi, Agnes Kiragga.

    2018

  • Integrating Cervical Cancer Screening into routine HIV clinical care for women: A retrospective study of adherence to screening guidelines in an Urban HIV center in Uganda

    Nabaggala Maria Sarah, Phelps Emma, Nakalema Shadia, Tibakabikoba Harriet, Zanika Bernadette, Kalule Ivan, Mohammed Lamorde, Castelnuovo Barbara, Kiragga Agnes

    2018

  • Socioeconomic Indicators and Sexually Transmitted Infections Prevalence In Uganda: Using A Hierarchical Statistical Approach On A Nationally Representative Data

    Godwin Anguzu, Andrew Flynn, Joseph Musaazi, Ronnie Kasirye, Agnes N Kiragga, and Andrew Mujugira

    2018

  • Socio-economic Disparities across Regions and their effect on risk of Sexually Transmitted Infections in Uganda

    Godwin Anguzu, Andrew Flynn, Joseph Musaazi, Ronnie Kasirye, Leonard K Atuhaire, Agnes N Kiragga1, Allen Kabagenyi2 and Andrew Mujugira

    2018

  • Long term risky sexual behavior among patients on antiretroviral therapy in urban and rural cohorts in Uganda: A longitudinal Prospective cohort study

    Stephen Okoboi,, Barbara Castelnuovo, David Moore, Joseph Musaazi, Andrew Kambugu, Elise De Vos, Josephine Birungi, Pontiano Kaleebu, Nanfuka Mastula, Moses Kamya8 Annelies Van Rie

    2018

  • Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda within the context of HIV test and treat: a cost-effectiveness modelling analysis

    2018

  • Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: a cost-effectiveness modeling analysis

    2018

  • DolPHIN-1 study group: Randomised controlled triak of dolutegravir (DTG)- Versus efavirenz(EFV) – based therapy in mothers initiating antiretroviral treatment in late pregnancy

    C.Orrell, K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Elsa, C Heiberg, C. Waitt, S. Walimbwa, E.M Hodel, A. Hill, S. Khoo, M. Lamorde

    2018

  • Pharmacokinetics of efavirenz 400g when administered with Rifampicin and Isoniazid in HIV-TB co-infected patients in Uganda.

    M. Lamorde, X. Wang, J.P. Kaboggoza, M. Neary, C Sekaggya-Wiltshire, S. Nakalema, A. Owen, M. McClure, M. Boffito

    2018

  • Sport betting Centers and Mobile Health Engagement: How to Find, Link and Retain Men for HIV prevention Or Treatment.

    J. Bwanika, A. Kirgga, D. Musinguzi, W. Lubega, L.H. Kamulegeya Y. Manabe

    2018

  • Paediatric Outcomes Among Infants Born To Hiv Positive Women Disengaged From A Pmtct Program In Uganda

    Ellon Twinomuhwezi, Agnes N. Kiragga, Barbara Castelnuovo, Grace Banturaki, Nampala J, Achieng M, Musick B, ,Yiannoutsos C , Wools-Kaloustian K

    2018

  • Missed Clinic appointments and long term retention of HIV positive adults in care in a large HIV Clinic In Uganda.

    Frank Mubiru, Kuteesa Bisaso, Barbara Castelnuovo, Joseph Mawejje, Noela Owarwo, Mohammed Lamorde and Agnes Kiragga.

    2018

  • High rates of lost to follow up during transition from youth friendly HIV clinics to Adult care in Urban Uganda

    Kiragga AN, Mubiru F, Bisaso RK, Onzia A, Lamorde M, Castelnuovo B

    2018

  • Residential Fertility Differences Among Women In Uganda: Application Of Non-Linear Oaxaca Blinder Decomposition

    Nabaggala Maria Sarah, Naomi Mucyo, Joseph Musaazi, Kiragga Agnes

    2018

  • Correlates of Hepatic Fibrosis among HIV-Infected Individuals from an Urban Infectious Diseases Clinic In East Africa.

    E M A benson, J Aizire, J Nabweteme, D L Thomas, E Seremba, S Reynolds, C Wekesa, A Kambugu, P Ocama, G D Kirk

    2018

  • High rates of lost to follow up during transition from youth friendly HIV clinics to Adult care in Urban Uganda

    Kiragga AN, Mubiru F, Bisaso RK, Onzia A, Lamorde M, Castelnuovo B.

    2018

  • Development and validation of an HPLC-UV multiplex assay for monitoring antiretroviral drugs in resource limited settings.

    Allan Buzibye, Amrei von Braun, Sarah Nanzigu, Christine Sekaggya, Barbara Castelnuovo, Andrew Kambugu, Jan Fehr, Stefanie Sowinsk, Ursula Gutteck, Daniel Mueller

    2018

  • Compliance to guidelines for Routine Viral Load testing in resource limited settings

    Barbara Castelnuovo1, Mubiru Frank1, Mark Nsumba 1, Ivan Lumu 1, Isaac Lwanga 1, Agnes Kiragga, Steven J Reynolds

    2018

  • Missed Clinic appointments and long term retention of HIV positive adults in care in a large HIV Clinic In Uganda.

    Frank Mubiru, Kuteesa Bisaso, Barbara Castelnuovo, Joseph Mawejje, Noela Owarwo, Mohammed Lamorde and Agnes Kiragga

    2018

  • Socio-economic Disparities across Regions and their effect on risk of Sexually Transmitted Infections in Uganda

    Godwin Anguzu, Andrew Flynn, Joseph Musaazi, Ronnie Kasirye, Leonard K Atuhaire, Agnes N Kiragga, Allen Kabagenyi and Andrew Mujugira

    2018

  • Causal relationship between risky sexual behavior and HIV testing among young adults (18-35 years) in Uganda: a Structural Equation Analysis

    Nabaggala Maria Sarah, Joseph Musaazi, Kiragga Agnes

    2018

  • Integrating Cervical Cancer Screening into routine HIV clinical care for women: A retrospective study of adherence to screening guidelines in an Urban HIV center in Uganda

    Nabaggala Maria Sarah, Phelps Emma, Nakalema Shadia, Tibakabikoba Harriet, Zanika Bernadette, Kalule Ivan, Mohammed Lamorde, Castelnuovo Barbara, Kiragga Agnes

    2018

  • The burden of chronic co-morbidities among HIV-infected adults in a large Urban HIV clinic in Uganda

    Musomba, Noela Owarwo, Maria Sarah Nabaggala, Mark Nsumba, John Matovu, Mohammed Lamorde, Barbara Castelnuovo

    2018

  • Virological Outcomes Among Young Adults At The Infectious Diseases Institute Kampala, Uganda

    Rachel Musomba, Nsumba Mark, Patience Nyakato, Arvind Kaimal, Tibakabikoba Harriet, Adeline Twimukye, John Matovu, Mohammed Lamorde, Barbara Castelnuovo

    20018

  • Long term risky sexual behavior among patients on antiretroviral therapy in urban and rural cohorts in Uganda: A longitudinal Prospective cohort study

    Stephen Okoboi, Barbara Castelnuovo, David Moore, Joseph Musaazi, Andrew Kambugu, Elise De Vos, Josephine Birungi, Pontiano Kaleebu, Nanfuka Mastula, Moses Kamya Annelies Van Rie

    2018

  • Influence of Decision Making Process on Uptake Of Hiv Testing Among Women In Uganda

    Sylvia Nabukenya, Sarah Nabaggala, Stephen Okoboi, Agnes Kiragga.

    2018

  • High risk of herbal medicine use in a cohort of HIV patients with comorbidities in a large urban HIV clinic in Uganda.

    Angella Sandra Namwase, Mubiru Frank, Christine Sekaggya, Barbara Castelnuovo, Rosalind Parkes-Ratanshi

    2018

  • Medications safety issues associated with currently used First Line Anti-retroviral regimens in Uganda

    Kay Seden, Daniel Kizza, Eva Laker, Joseph Walter Arinaitwe, Catriona Waitt, Mohammed Lamorde, Saye Khoo

    2018

  • Diagnostic utility of multiplex PCR in an HIV infected population with meningitis

    Sarah Bridge et al

    2018

  • Etiologies of symptomatic recurrence in HIV associated cryptococcal meningitis

    Emily Evans et al

    2018

  • High Mortality associated with unmasking cryptococcal meningitis

    Kathy Huppler-Hulsiek et al

    2018

  • Differential brain tissue penetration of antiretrovirals and fluconazole.

    Melanie Nicol et al

    2018

  • Adjunctive sertraline in HIV-associated cryptococcal meningitis.

    Josh Rhein et al

    2018

  • Customized amphotericin duration for cryptococcal meningitis based on fungal burden

    Kenneth Ssebambulidde et al. Symptomatic cryptococcal antigenemia presenting as early cryptococcal meningitis 7. Darlisha Williams et al

    2018

  • Cyp2b6 Variants Alter Etonogestrel Pharmacokinetics When Combined With Efavirenz

    Megan Neary, Catherine Chappell, Kimberly K. Scarsi, Shadia Nakalema, Joshua Matovu, Sharon L. Achilles, Beatrice Chen, Marco Siccardi, Andrew Owen, Mohammed Lamorde

    2018

  • Dolutegravir Interactions with Artemether-Lumefantrine and Amodiaquine-Artesunate

    Stephen I. Walimbwa1, Mohammed Lamorde1, Catriona Waitt2, Julian P. Kaboggoza1, Laura Else2, Pauline Byakika-Kibwika3, Alieu Amara2, Joshua Gini2, Markus Winterberg4, Joel Tarning4, Saye Khoo2

    2018

  • Compliance to Guidelines for Routine Viral Load Testing In Resource Limited Settings

    Barabara Castelnuovo, Frank Mubiru, Mark Nsumba, Isaac Lwanga, Ivan Lumu, Agnes Kiragga, Steven J. Reynolds

    2018

  • Dolutegravir Vs Efavirenz When Initiating Treatment In Late Pregnancy.

    Catriona Waitt1, Stephen I. Walimbwa2, Catherine Orrell3, Mohammed Lamorde2, Christie Heiberg3, Ushma Mehta4, Julian P. Kaboggoza2, Julie Anne Coombs3, Josaphat Byagumisha2, Alieu Amara1, Thoko Malaba4, Laura Else1, Landon Myer4, Saye Khoo1, for the DolPHIN-1 Study Group. Dolphin-

    2018

  • Role of Chest X-Ray In The Diagnosis Of HIV-Associated Smear-Negative Tuberculosis In Uganda,

    Lydia Nakiyingi, John Mark Bwanika, Willy Ssengooba, Frank Mubiru, Harriet Mayanja-Kizza, Jerold Ellner, Susan E Dorman, Yukari C Manab

    2018

  • Improved Virological Outcomes In Co-Pay Hiv Clinic As A Model Of Differentiated Care.

    R Parkes-Ratanshi, S Lewis, M S Nabaggala, A Tumikye, T Kakaire, N Owarwo, A Kiragga, B Castlenuovo, W Schlech, M Lamorde

    2017

  • Developing Media to promote Community Awareness of Early Detection of Kaposis Sarcoma In Africa.

    Miriam Laker-Oketta, Lisa Butler, Philippa Makanga, Toby Maurer, Edward Mbidde, & Jeffrey Martin

    2018

  • Sustain Favourable TB Treatment Outcomes over 7 years of Integrated TB & HIV Services in a Large Urban Cohort in Uganda.

    Joseph Musaazi, Christine Sekagya-Wiltshire, Agnes Kiragga, Ivan Kalule, Barbara Castelnuovo

    2018

  • Reason for changing First line ART: the Role of toxicities over 12 years In a large urban program In Uganda

    Barbara Castelnuovo, Frank Mubiru Ivan Kalule, Isaac Lwanga & Agnes Kiragga.

    2018

  • Poor Outcome Among Women who disengage from PMTCT services In Urban Uganda.

    Kiragga AN, Castelnuovo B, Twinomuhwezi E, Banturaki G, Nampala J, Achieng M, Musick B, Wolls-Kaloustiann K, Yiannoutsos C

    2017

  • Capacity building of early career researchers using the Gilead Infectious Diseases training program at Infectious Diseases Institute: Achievements and challenges

    Angella Sandra Namwase1, Stephen Okoboi1, Allen Mukhwana2, Barbara Castelnuovo1, Andrew Kambugu

    2017

  • , Exploring attitudes and perceptions of patients and staff towards “Call for life” system for HIV antiretroviral therapy in Uganda: A qualitative study.

    Adelline Twimukye

    2017

  • Cardiovascular risk prediction in a cohort of HIV ART experienced patients in Uganda: A comparison of the DAD and WHO/ISH CVD risk score models.

    Frank Mubiru, Agnes Kiragga, Barbara Castelnuovo, Steven J. Reynolds, Rosalind Parkes-Ratanshi

    2017

  • Antibiotic use in Uganda Outpatients taking Current Antiretrovirals

    Kay seden, Kizza D, Laker E, Arinaitwe JW, Waitt C, Lamorde M, Khoo S

    2017

  • Developing Media to promote Community Awareness of Early detection of Kaposi’s Sarcoma In Africa

    Miriam Laker-Okette, Lisa Butler, Philippa Makanga, Edward Mbidde & Jeffrey Martin

    2017

  • Training Community Health workers about Early Detection Of Kaposi’s Sarcoma: A comparison of expert-led versus community health worker supervisor-led approaches.

    Philippa Kadama-Makanga, Miriam Laket-Oketta, Lisa Butler, Andrew Kambugu, Toby Maurer, Edward Mbidde and Jeffrey Martin.

    2017

  • Prevalence and Determinants of High Risks Human Papillomavirus mRNA Detected Through Community-based Cervical Cancer Screening In Uganda.

    Miriam Nakalembe, Philippa Kadama, Megan Swanson, Jeffrey Martin and Megan Huchko

    2017

  • Prevention and Early Detection of Cervical Cancer In Africa through Community-Based Self – administered Screening and mobile treatment provision.

    Miriam Nakalembe, Philippa Kadama, Megan Swanson, Jeffrey Martin and Megan Huchko.

    2017

  • A Newly Esterblished Prospective Cohort in the ART Era Of Community Based Newly Diagnosed HIV Related Kaposi’ Sarcoma In Africa.

    Hellen Byakwaga, Aggrey Semeere, Naftali Busakhala, Esther Freeman, Miriam Laker-Oketta, Elyne Rotich, Megan Wenger, Job Kisubya, Aileen Chang, Toby Maurer and Jeffrey Martin

    2017

  • Feasibility of using Rapid Case Ascertainment to Evaluate Kaposi’ Sarcome In Africa

    Aggrey Semeere, Naftali Busakhala, Esther Freeman, Miriam Laker-Oketta, Elyne Rotich, Megan Wenger, Job Kisubya, Edwin Sang, Kara woold-Kaloustian, and Jeffrey Martin

    2017

  • Portable Confocal Microscopy as a Diagnosis Tool for Kaposi Sarcoma In Africa.

    Esther E Freeman, Aggrey Semeere, Priscilla Namaganda, Miriam Laker-Oketta, Robert Lukande, Divya Seth, Guilermo Tearney, Salvador Gonzalez, Milind Rajadhyyasksha, R.Rox Anderson Jeffrey Martin and Dongkyun Kang

    2017

  • Real world use of ART and Chemotherapy for Kaposi Sarcoma In A Large Community Based HIV Health care Network In Kenya.

    E Freeman, Naftali Busakhala, Fredrick Chite Asirwa, Susan Regan, Megan Wenger, Khatiya Chelidze, Aggrey Semeere, Ingrid Bassett, Kara woold-Kaloustian, and Jeffrey Martin

    2017

  • Nucleic Acid Amplification Testing as a Means for Diagnosis of Kaposi Sarcoma In Africa

    Jeffrey Martin, Aggrey Semeere, Ryan Snodgress, Priscilla Namaganda, Andrea Gardner, Megan Wegner, Esther E Freeman, Toby Maurer, Robert Lukande, Miriam Laker-Oketta, David Erickson, Ethel Cesarman

    2017

  • Feasibility of Using Rapid Case Ascertainment to Evaluate Kaposi Sarcoma in Africa

    Aggrey Semeere, Esther Freeman, Helen Byakwaga, Naftali Busakhala, Megan Wenger Elyne Rotich, Job Kisuya, Edwin Sang, Kara Wools-Kaloustian, and Jeffrey Martin

    2017

  • Timing Of Antiretroviral Therapy And Chemotherapy For Kaposi’s Sarcoma In A Large Community-Based Hiv Health Care Network In Kenya

    Esther Freeman, Naftali Busakhala, Fredrick Chite Asirwa, Susan Regan, Aggrey Semeere, And Jeffrey Martin.

    2017

  • Viral Hepatitis, Schistosomiasis as Risk Factors for Hepatocellular Carcinoma in Uganda.

    J Nabweteme, J Aizire ,EM Benson4, P Ocama, GD Kirk. Viral Hepatitis

    2017

  • Describing the use of long acting reversible contraceptive methods in a large urban HIV program in Uganda.

    Shadia Nakalema, Baker Richard, Frank Mubiru, John Michael Matovu, Ivan Kalule, Annet Onzia and Barbara Castelnuovo

    2017

  • Advocates for patient safety in a large HIV outpatient facility: feasibility and impact of a pilot training program in Uganda

    Seden K, Kukundakwe M, Kamoga R, Musomba R, Tindyebwa E, Lamorde M

    2017

  • Innovating to improve health worker Continuous Professional Development (CPD): Challenges in evaluating utilisation of interactive online resources in Uganda

    Ruth Kikonyogo, Joseph Walter Arinaitwe, Linda Namara, Umaru Ssekabira, Paul Buyego, Solome Okware; Rosalind Parkes-Ratanshi

    2017

  • Risk factors for viral failure among HIV patients on antiretroviral therapy (ART) at the Infectious Diseases Institute Kampala Uganda

    Nsumba Mark

    2017

  • Risk factors for viral failure among HIV patients on antiretroviral therapy (ART) at the Infectious Diseases Institute Kampala Uganda

    Nsumba Mark, Rachel Musomba, Arvind Kaimal, Harriet Bakabikoba, Frank Mubiru, Mohammed Lamorde, Barbara Castelnuovo.

    2017

  • Prevalence, Factors and Preferred HIV-diagnosis Disclosure Methods among Adolescents living with HIV: A mixed methods study

    C.P. Namisi

    2017

  • 4. Describing the continuum of care in young adults who transition from adolescent to adult care

    Barbara Castelnuovo et al

    2917

  • Efficacy of Option B-plus in a cohort of mother with high retention in averting paediatric transmission: low rates of transmission but high proportion of unreported outcomes,

    Barbara Castelnuovo et al

    2017

  • Shadia et al Tolerability and satisfaction of levonorgestrel versus etonogestrel contraceptive implants among women living with HIV

    2017

  • Fungal Induce severe Asthma Among Ugandans

    Richard Kwezira, Freddie Bwanga, William Worodria, Robin Gore, Stephen Fowler

    2017

  • Towards More Accurate Determination of cancer Survival In Resource – Limited Settings: Tracking Patients with Kaposi Sarcoma Who are Lost To Follow-up In Sub-Saharan Africa

    Aggrey Semmeere, Esther Freeman, Megan Wenger, Mwebesa Bwana, Michael Kanyesigye, Fredrick Chite Asirwa, Elyne Rotich, Naftalia Busakhala, Emmanuel Oga, Elima Jedy-Agaba, Vivian Kwaghe, Kenneth Iregbu, Clement Adebamowo, Antoine Jaquet, Francois Dabis, Sam Phiri, Julia Bohlius, Eliane Rohner, Constantin Yiannoutsos, Dave Glidden, Kara Wools-Kaloustian, & Jeffrey Martin

    2017

  • Cerebral Oximetry for Guiding Management in Cryptococcal Meningitis.

    John Diehl, Michael Okirwoth, Kathy H Hullsiek, Joshua Rhein, Nicole Stephens, David B Meya, David R Boulware, Abdu K Musubire, on behalf of the ASTRO-CM Trial Team

    2017

  • Reasons for LTFU and levels of HIV Sero-Status Disclosure among routine patients receiving care in urban Uganda

    Agnes N Kiragga, Patience Nyakato, Martin Ssuna, Edison Katunguka, Louise Nassuna, Joanita Kigozi

    2017

  • Feasibility of reporting the efficacy of Option B-plus in a Cohort of Mother with high retention in averting paediatric Transmission: Low rates of transmission but high proportion of unreported outcomes

    Mubiru Frank, Castelnuovo Barbara, Kalule Ivan, Musomba Rachel, Mackline Hope, Nakalema Shadia & Kiragga Agnes.

    2017

  • Correction of estimates of retention for newly diagnosed HIV positive patients before the Initiation of ART In Uganda: A sample based approach

    Nyakato P, Kiragga A, Kambugu A, Ssuuna M, Bradley J, Baisley K.

    2017

  • Describing the continuum of care in young adults who transition from adolescent to adult care

    Castelnuovo Barbara, Mubiru Frank, Twimukye Adelline, Nakalema Shadia, Kiragga Agnes

    2017

  • Efavirenz- but not nevirapine-based antiretroviral therapy significantly reduces etonogestrel concentrations in HIV+ women using subdermal contraceptive implants

    2016

  • High rates of multi-class drug resistance in HIV-1 infected individuals monitored with CD4 cell count in Uganda

    Amrei Von Braun

    2016

  • Pharmacokinetic evaluation of efavirenz- and nevirapine-based antiretroviral therapy plus etonogestrel contraceptive implants

    Chappell, Catherine

    2016

  • Low rifampicin and isoniazid concentrations are associated with delayed sputum conversion in HIV-positive patients co-infected with tuberculosis in Uganda

    Sekaggya, Christine

    2016

  • Improved adherence to antiretroviral treatment observed among children whose caregivers had positive beliefs in Medicine.

    G Abongomera, A Cook, V Musiime, C Chabala, M Lamorde, J Abach, M Thomason, V Mulenga, AKekitinwa, R Colebunders, CKityo, AS Walker & DM Gibb on behalf of the CHAPAS-3 trial team

    2016

  • . Impact of Religiosity on HIV/AIDS Patient Retention in Care and Art Adherence in Uganda: A case study of the Infectious Diseases Institute Kampala Uganda

    Adelline Twimukye1, Charles B. Rwabukwali , Joseph B. Sempa , Agnes Kiragga Mohammed Lamorde, Judy Orikiiriza, Andrew Kambugu

    2016

  • Implementation of routine viral load monitoring in a large urban clinic in Uganda

    Nsumba Mark, Musomba Rachel, Arvind Kaimal, Harriet Tibakabikoba, Lwanga Isaac, Mohammed Lamorde, Castelnuovo Barbara.

    2016

  • High rates of loss to follow-up among women on option B+ program attending care in urban Uganda.

    Agnes N. Kiragga, Barbara Castelnuovo, Edison Katunguka, Rhoda Mwonda, Joanita Kigozi

    2016

  • Describing point of entry into care and lost to program in a cohort of HIV positive pregnant women in a large urban center in Uganda.

    Frank Mubiru, Agnes Kiragga, Shadia Nakalema, Hope Mckline, Ivan Kalule, Rosalind Parkes Ratanshi, Barbara Castelnuovo.

    2016

  • Virological Outcomes of Patients on Second line ART (boosted atazanavir versus boosted lopinavir)

    E. Laker Agnes Odongpiny1, D. Nalwanga1, A. Kaimal1, A. Kiragga2, S.M. Nabaggala2, B. Castelnuovo2, R. Parkes-Ratanshi

    2016

  • Task sharing: Evaluation of intensive clinical mentorship on mid-level practitioners’ management of TB and HIV

    Sarah Naikoba, Dan Kaggwa Senjovu , Pallen Mugabe; Patricia L. Riley; Carey McCarthy; Damazo T. Kadengye; Shona Dalal.

    2016

  • Detrimental Outcomes Of Unmasking Cryptococcal Meningitis With Recent Art Initiation

    Joshua Rhein,Kathy Huppler Hullsiek,Emily E. Evans,Lillian Tugume, Edwin Nuwagira,Reuben Kiggundu, Edward Mpoza, Abdu Musubire,Mollie Roediger, Kabanda Taseera, Darlisha A Williams, Mahsa Abassi, Conrad Muzoora, David B. Meya, David R. Boulware on behalf of ASTRO-CM Study Team

    2016

  • PD-1 Expression on Peripheral Blood Plasma Blasts and Plasma Cells B Cells at Baseline is Associated with Survival in HIV-1 Infected ART-Naïve Cryptococcal Meningitis

    Okurut S, Meya DB, Bwanga , Jallow , Kambugu A, Olobo J, Eller MA, Kiweewa F, Kibuuka H, Zziwa G, Naluyima P, Bohjanen PR, Pratap H5, Boulware DR6, Janoff EN5, on behalf of the COAT Trial & ASTRO Study Team

    2016

  • Defective’ Cd4+ Cells And Susceptibility To Cryptococcal Meningitis In Individuals With Cd4 Count ≥100.

    3. Lillian Tugume, Reuben Kiggundu, Mollie P Roediger, Henry W Nabeta, Abdu Musubire, Conrad Muzoora, Darlisha A Williams, Mahsa Abassi, Nathan C Bahr, Graeme Meintjes, Kathy H Hullsiek, Joshua Rhein, David B Meya, David R Boulware

    2016

  • Predicting Sterility From Baseline Quantitative Fungal Culture; A Role For Customizing Therapy In Cryptococcal Meningitis?

    Darlisha A Williams, Bozena M Morawski, Lillian Tugume, Reuben Kiggundu, Edward Mpoza, Henry Nabeta, Tony Luggya, Mahsa Abassi, Andrew Akampurira, Mollie Roediger, Kathy Huppler Hullsiek, David R. Boulware, David B. Meya, Joshua Rhein, On Behalf Of ASTRO-CM Study Team

    2016

  • Rapid Detection of CSF Sterility with Trypan Blue Using a Haemocytometer and TC20 Automated Counter Among HIV Patients with Cryptococcal Meningitis

    Richard Kwizera, Andrew Akampurira, Olive Mbabazi, Tadeo K Kandole, Reuben Kiggundu, Maria S Nabaggala, Kirsten Nielsen, Andrew Kambugu, David B Meya, Joshua Rhein, David R Boulware

    2016

  • Cryptococcus Neoformans Titan Cells fool the host Immune system

    Liliane Mukaemera, Darin Wiesner, Keunsook K Lee, Neil Gow, Kirsten.

    2016

  • Oral PrEP enhances genital HIV-neutralizing IgAIn HIV -1 exposed seronegative (HESN) women

    Jennifer M. Lund; Kristina Broliden; Maria N. Pyra; Katherine K. Thomas; Deborah Donnell; Elizabeth Irungu; Timothy R. Muwonge; Nelly R. Mugo; Jared M. Baeten; Jairam R. Lingappa

    2016

  • Short Message Service (SMS) Survey Assesing Pre-Exposure Prophylaxis (PrEP) Adherence and Sexual Behavior are Highly Acceptable among HIV-Uninfected Members of Serodiscordant Couples In East Africa.

    Timothy Muwonge

    2016

  • Responsible PrEP use: A qualitative Analysis of PrEP Adherence In Ugandan HIV Uninfected Partners In Serodiscordant Relationship.

    Norma Ware, Jessica Haberer, Timothy Muwonge, Emily Pisarski, Monigue Wyatt, Melanie Tam

    2016

  • . “It Was Easy”: A qualitative Analysis of Participants’ Experience Responding to Short Messages Service (SMS) surveys on Pre-Exposure Prophylaxis

    Jessica Haberer, Jared Baeten, Renee Heffron, Elly Katabira, Nelly Mugo, Bridget Burns,Betty Nankya, Grace Kimemia, Timothy Muwonge.

    2016

  • Prevention-Effective Adherence per Short Message Service (SMS) within a demonstration Project of Pre-Exposure Prophylaxis (PrEP) Among HIV-Serodiscordant Couples In East Africa.

    Jared Baeten,Connie Celum, Renee Heffron, David Bangsberg, Bridget Burns, Nicholas Musinguzi, Lara Kidoguchi, Elly Katabira, Nelly Mugo

    2016

  • Prevention-Effective Adherence In Demonstration Project of Pre-exposure Prophylaxis (PrEP) Among HIV SerodiscordantCouples In East Africa

    Renee Heffron, Jared Baeten, Connie Celum, Stephen Assimwe, Elly Katabira, Elizabeth Bukusi, Nelly Mugo, Lara Kidoguchi, Jessica Haberer

    2016

  • Describing point of entry into care and lost to program in a cohort of HIV positive pregnant women in a large urban center in Uganda

    Castelnuovo B, Mubiru F, Nakalema S, Mckline H, Kalule I, Parkes Ratanshi R, Kiragga A

    2016

  • High rates of loss to follow-up among women on option B+ program attending care in urban Uganda

    Agnes N. Kiragga, Barbara Castelnuovo, Edison Katunguka, Rhoda Mwonda, Joanita Kigozi

    2016

  • PK of FTC, TFV and 3TC in Ugandan and Nigerian Breastfeeding Mother-Infant Pairs

    Catriona Waitt, Adeniyi Olagunju, Shadia Nakalema, Isabella Kyohaire, Andrew Owen, Mohammed Lamorde, Saye Khoo

    2016

  • Transcriptomic Signature of Atorvastatin Response Among ART-Treated Adult In Africa

    Nakanjako D, Ghneim K, Ssinabulya I, Bayigga L, Kiragga A, Kamya MK, Kambugu A, Kaleebu P, Elliot AM, Sekaly RP

    2016

  • Atorvastatin Reduced T-Cell Activation and Exhaustion among Suboptimal Immune Responders: A Randomized Crossover Placebo Controlled Trial

    Damalie Nakanjako, Ssinabulya I, Nabatanzi R, Bayigga L, Kiragga A, Kambugu A, Kaleebu P, Elliot AM, Kamya MK, Sekaly RP, Mayanja-Kizza H.

    2016

  • Pre-ART Cryptococcal Antigen Titer is Associated with Failure of Preemptive Fluconazole Therapy.

    Morawski BM, Boulware DR, Nalintya E, Kiragga A, Kakooza F, Rajasingham R, Park BJ, Manabe YC, Kaplan JE, Meya DB

    2016

  • Neurocognitive Function in HIV-Infected Persons With Cryptococcal Antigenemia

    Martha P. Montgomery; Noeline Nakasujja; Bozena M. Morawski, Radha Rajasingham; Elizabeth Nalintya; Renee Donahue Carlson; Jona E. Kaplan; Andrew Kambugu; David B. Meya; David R. Boulware; for the on behalf of the COAT and ORCAS Trial Teams.

    2016

  • Immunologic Discrimination of Cryptococcal IRIS from Culture-Positive Relapse

    David R. Boulware; Joshua R. Rhein; Edward N. Janoff; Abdu Musubire; Andrew Kambugu; Paul Bohjanen; David B. Meya; for the COAT Trial Team

    2016

  • Responsible PrEP use: A qualitative Analysis of PrEP Adherence In Ugandan HIV Uninfected Partners In Serodiscordant Relationship.

    Norma Ware, Jessica Haberer, Timothy Muwonge, Emily Pisarski, Monigue Wyatt, Melanie Tam

    2016

  • “It Was Easy”: A qualitative Analysis of Participants’ Experience Responding to Short Messages Service (SMS) surveys on Pre-Exposure Prophylaxis (PrEP) Adherence and sexual Behavior in East Africa.

    Jessica Haberer, Jared Baeten, Renee Heffron, Elly Katabira, Nelly Mugo, Bridget Burns,Betty Nankya, Grace Kimemia, Timothy Muwonge

    2016

  • Prevention-Effective Adherence per Short Message Service (SMS) within a demonstration Project of Pre-Exposure Prophylaxis (PrEP) Among HIV-Serodiscordant Couples In East Africa

    Jared Baeten,Connie Celum, Renee Heffron, David Bangsberg, Bridget Burns, Nicholas Musinguzi, Lara Kidoguchi, Elly Katabira, Nelly Mugo, Timothy Muwonge, Kenneth Ngure, Jessica Haberer

    2016

  • Prevention-Effective Adherence In Demonstration Project of Pre-exposure Prophylaxis (PrEP) Among HIV SerodiscordantCouples In East Africa.

    Renee Heffron, Jared Baeten, Connie Celum, Stephen Assimwe, Elly Katabira, Elizabeth Bukusi, Nelly Mugo, Lara Kidoguchi, Jessica Haberer

    2016

  • Describing point of entry into care and lost to program in a cohort of HIV positive pregnant women in a large urban center in Uganda

    Castelnuovo B, Mubiru F, Nakalema S, Mckline H, Kalule I, Parkes Ratanshi R, Kiragga A

    2016

  • High rates of loss to follow-up among women on option B+ program attending care in urban Uganda

    Agnes N. Kiragga, Barbara Castelnuovo, Edison Katunguka, Rhoda Mwonda, Joanita Kigozi

    2016

  • PK of FTC, TFV and 3TC in Ugandan and Nigerian Breastfeeding Mother-Infant Pairs

    Catriona Waitt, Adeniyi Olagunju, Shadia Nakalema, Isabella Kyohaire, Andrew Owen, Mohammed Lamorde, Saye Khoo

    2016

  • Transcriptomic Signature of Atorvastatin Response Among ART-Treated Adult In Africa

    Nakanjako D, Ghneim K, Ssinabulya I, Bayigga L, Kiragga A, Kamya MK, Kambugu A, Kaleebu P, Elliot AM, Sekaly RP

    2016

  • Atorvastatin Reduced T-Cell Activation and Exhaustion among Suboptimal Immune Responders: A Randomized Crossover Placebo Controlled Trial

    Damalie Nakanjako, Ssinabulya I, Nabatanzi R, Bayigga L, Kiragga A, Kambugu A, Kaleebu P, Elliot AM, Kamya MK, Sekaly RP, Mayanja-Kizza H

    2016

  • Pre-ART Cryptococcal Antigen Titer is Associated with Failure of Preemptive Fluconazole Therapy.

    Morawski BM, Boulware DR, Nalintya E, Kiragga A, Kakooza F, Rajasingham R, Park BJ, Manabe YC, Kaplan JE, Meya DB

    2016

  • Neurocognitive Function in HIV-Infected Persons With Cryptococcal Antigenemia.

    Martha P. Montgomery; Noeline Nakasujja; Bozena M. Morawski, Radha Rajasingham; Elizabeth Nalintya; Renee Donahue Carlson; Jona E. Kaplan; Andrew Kambugu; David B. Meya; David R. Boulware; for the on behalf of the COAT and ORCAS Trial Teams

    2016

  • Immunologic Discrimination of Cryptococcal IRIS from Culture-Positive Relapse

    6. David R. Boulware; Joshua R. Rhein; Edward N. Janoff; Abdu Musubire; Andrew Kambugu; Paul Bohjanen; David B. Meya; for the COAT Trial Team

    2016

  • Pre-ART Cryptococcal Antigen Titer Associated With Preemptive Fluconazole Failure

    Bozena M. Morawski1; David R. Boulware1; Elizabeth Nalintya2; Agnes Kiragga2; Francis Kazooza2; Radha Rajasingham1; Benjamin J. Park3; Yukari C. Manabe4; Jona E. Kaplan3; David B. Meya

    2016

  • Increase in CD4 Counts at Presentation to ART Care Among Urban HIV Clinics in Uganda

    Elizabeth K. Nalintya1, Agnes N. Kiragga1, Edison Katunguka2, Henry W. Nabeta1, Joanita Kigozi1, Yukari Manabe4, David R. Boulware2, Jon Kaplan3, David B. Meya

    2016

  • Comparative Efficacy of six Aspergillus-specific IgG Assays for the Diagnosis of Allergic Bronchopulmonary Aspergillosis(ABPA)

    Ian D Page, Richard Kwizera, Malcolm Richardson, David W Denning

    2016

  • Exploring Attitudes And Perceptions Of Patients And Staff Towards A Fee For Service “After Hours” Clinic Supplementing Free Hiv Services In Uganda: A Qualitative Study

    Adelline Twimukye, Rachel King, Walter Schlech, Faridah Mayanja, Tom Kakaire, Rosalind Parkes Ratanshi.

    2015

  • Long Term Virological Outcomes Of Hiv Infected Patients On Antiretroviral Treatment In Uganda

    Barbara Castelnuovo, Agnes N Kiragga, Frank Mubiru, Andrew Kambugu, Steve Reynolds

    2015

  • Monitorinbgd Of cyptoccosis Results to IUmprove Qua;ity pf Patients Care In a large Urban Clinic In Uganda

    Musomba Rachel, Castelnuovo, Mark Nsumba, Ivan Kalule, Parkes Ratanshi Rosalind

    2015

  • The 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), which will be held from 25 – 28 April 2015 in Copenhagen, Denmark

    C. Sekaggya, A. von Braun, Ledergerber B, Buzibye A, Scherrer A, Lamorde M, Nalwanga D , L. Henning, Muller D, Gutteck U, B. Castelnuovo, A. Kambugu, J. Fehr

    2015

  • Low isoniazid and rifampicin concentrations in TB/HIV co-infected patients in Uganda

    Sekaggya C, Lamorde M, Scherrer A.U, Musaazi J, Corti N, Buzibye A, Nakijoba R, Nalwanga D, Henning L, von Braun A, Okware S, Castelnuovo B, Kambugu A, Fehr J

    2015

  • Safety and Tolerability of a fixed dose combination tablet containing tenofovir disoproxil fumarate, emtricitabine plus rilpivirine in HIV-1 infected Ugandans

    Stephen I. Walimbwa¹, Frank Mubiru¹, Mohammed Lamorde

    2015

  • Immune Reconstitution and Viralogic Response Amongst Malnourished And Well Nourished Antiretroviral Experienced Children In Uganda.

    J. T. Orikiiriza

    2015

  • Outcomes of HIV-infected individuals after ten years on antiretroviral therapy

    Gonza K. Paul , Kiragga Agnes , Mubiru Frank, Wanyama Jane, Wandera Bonnie, Kamya Moses, Kambugu Andrew, Castelnuovo Barbara.

    2015

  • Clinical decision and outcomes of patients suspected of treatment failure and tested for HIV-viral load at the Infectious Diseases Institute (IDI), Kampala, Uganda

    M.S. Nsumba, C. Barbara, R.Z. Musomba, A. Kaimal, K. Ivan, L. Isaac, J. Laurence, P.-R. Rosalind, K. Andrew

    2015

  • Renal Safety of Tenofovir and Amphotericin co-administration in Cryptococcosis

    Reuben Kiggundu , Bozena M Morawski , Nathan C Bahr , Abdu Musubire, Darlisha Williams, Kathy Huppler Hullsiek, Mahsa Abassi, Joshua Rhein, David B Meya, David R Boulware

    2015

  • The 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), which will be held from 25 – 28 April 2015 in Copenhagen, Denmark.

    C. Sekaggya, A. von Braun, Ledergerber B, Buzibye A, Scherrer A, Lamorde M, Nalwanga D , L. Henning, Muller D, Gutteck U, B. Castelnuovo, A. Kambugu, J. Fehr

    2015

  • Low isoniazid and rifampicin concentrations in TB/HIV co-infected patients in Uganda

    5.Sekaggya C, Lamorde M, Scherrer A.U, Musaazi J, Corti N, Buzibye A, Nakijoba R, Nalwanga D, Henning L, von Braun A, Okware S, Castelnuovo B, Kambugu A, Fehr J

    2015

  • Lack of clinically significant interaction between the levonorgestrel implant and nevirapine-based antiretroviral therapy.

    Kristin M. Darin, Shadia Nakalema, Laura Else, Pauline Byakika-Kibwika, David J. Back, Sujan Dilly-Penchala, Susan E. Cohn, Concepta Merry, Mohammed Lamorde, Kimberly K. Scarsi

    2015

  • Correlation between efavirenz and levonorgestrel plasma concentrations during a drug-drug interaction study.

    Kimberly K. Scarsi, Kristin M. Darin, Shadia Nakalema, David J. Back, Pauline Byakika-Kibwika, Laura Else, Sujan Dilly-Penchala, Concepta Merry, Susan E. Cohn, Mohammed Lamorde

    2015

  • Mortality After Diagnosis of Kaposi ’s sarcoma Among HIV-infected Adults in Sub-Saharan Africa: Overcoming High Losses to Follow-up to Derive More Accurate Inferences

    Aggrey Semeere, Esther Freeman, Megan Wenger, Naftali Busakhala, Elyne Rotich, Chite Asirwa, Mwebesa Bwana, Michael Kanyesigye, Toby Maurer, David Glidden, Constantin Yiannoutsos, Kara Wools-Kaloustian, and Jeffrey Martin

    2015

  • Long term durability of fiRst line in a cohort of patients started on ART and followed up for 10 years in Uganda

    Barbara Castelnuovo, Agnes Kiragga, Frank Mubiru, Andrew Kambugu, Moses Kamya, Steve Reynolds

    2015

  • Characteristics and outcomes of patients assessing HIV care and treatment through different modality of entry in a large urban clinic in Uganda.

    Castelnuovo B, Musaazi J, Musomba R, Parkes-Ratanshi R, Kiragga A.

    2015

  • Neurocgnitive Function In Africans Failing First Line ART & Responses to Second Line

    Andrew D Kambugu, Jennifer Thompson, James G. Hakim, Dinah Tumukunde, Joep Van Oosterhout, Anne Hoppe, Charles Kwobah, Sarah Walker, Nicholas Paton

    2015

  • Second-Line Treatment In Sub-Saharan Africa; Week 144 Follow – up of the EARNEST Trial.

    James G. Hakim, Jennifer Thompson, Cissy M Kityo, Sarah Walker, Joep Van Oosterhout, Anne Hoppe, Andrew D Kambugu, Peter Mugyenyi, Nicholas Paton. On behalf of the EARNEST Trial Team.

    2015

  • Levonorgestrel Implant + EFV-Based ART: Unintended Pregnancies and Associated PK Data

    Kimberly K. Scarsi, Kristin M.Darin, Shadia Nakalema, David Back, Pauline Byakika-Kibwika, Laura Else, Sujan Dilly-Penchala, Susan Cohn, Concepta Merry, Mohammed Lamorde

    2015

  • Prognostic Model for Patients with Kaposi Sarcoma Treated With ART Alone In Africa

    Miriam O. Laker-Oketta, David V Glidden, Victoria Walusansa, Jackson Orem, A. Rain Mocello, Toby Maurer, Peter W Hunt, Andrew Kambugu, Edward Mbidde, Jeffery Martin

    2015

  • Cerebrospinal Fluid Cytokines and HIV-Associated Neurocognitive Disorders In Uganda.

    Gertrude Nakigozi, Noeline Nakasujja, Xiangrong Kong, David B Meya, Kevin Robertson, Ronald H. Gray, Maria J. Wawer, Ned Sacktor, David R Boulware

    2015

  • Impact Of NRTI Cross-Resistance on Second Line PI + NRTI Therapy Outcomes In Africa

    Nicholas Paton, Cissy M Kityo, Jennifer Thompson, Leonard Bagenda, James Hakim, Joeb Van Oosterhout, Andrew d Kambugu, Anne Hoppe, Sarah Walker. On Behalf Of the EARNEST Trial Team

    2015

  • Atorvastatin Reduced T-Cell Activation and exhaustion Among sub-optimal Immune Responders: A Randomized Crossover Placebo Controlled Trial

    Damalie Nakanjako

    2015

  • Increases In CD4 Counts at Presentation of Care During the ART Era Among Urban HIV Clinic In Kampala Uganda

    Elizabeth K Nalintya, Agnes N Kiragga, Edison Katunguka, Henry W Nabeta, Joanita Kigozi, Yukari C Manabe, David R Boulware, Jonathan E Kaplan, David B Meya

    2015

  • Hepatitis B vaccine response in Pediatric patients attending Rwanda Military Hospital

    Louis Mujuwisha, Elizabeth Karlsson, Vincent Mutabazi, Johan Normark, Judy Orikiiriza

    2015

  • High Mobility Group Box(HMGB1) and HIV-Associated Kaposi Sarcoma In Africa

    Peter W. Hunt, Miriam O. Laker-Oketta, Albert R. Davalos, Conrad Muzoora, David V Glidden, A. Rain Mocello, David R. Bangsberg, Edward Mbidde, Jeffrey N Martin

    2015

  • Facility-Level Factors Influeincing Retention In HIV Care In East Africa.

    Beth Rachlis, Glorgos Bakoyannis Philippa Easterbrook, R. Scott Braithwaite, Craig R Cphen Elizabeth Bukusi, Andrew D Kambugu, Mwebesa Bosco Bwana, Elvin H. Geng, Paula Braitstein

    2015

  • Monitoring and Switching of First-line ART in sub-Saharan Africa.

    Haas AD, Keiser O, Dabis F, Davies MA3, Parkes-Ratanshi R, Reynolds SJ, Wools-Kaloustian K, Wandeler G , Egger M for IeDEA collaboration

    2015

  • Detrimental Outcomes Of unmasking Cryptococcal Meningitis with Recent ART Initiation

    Joshua Rhein, Kathy Huppler Hullsiek, Nathan C Bahr, Reuben Kiggundu, Darlisha A Williams, Henry W Nabeta, Abdu Musubire, David B Meya, David R Boulware

    2015

  • Adjunctive Sertraline for the treatment of HIV-Associated Cryptococcal Meningitis

    14. Joshua Rhein, Kathy Huppler Hullsiek, Bozena M Morawski, Kyle D Smith, Ali Al-Hadab, Abdu Musubire, Darlisha A Williams, Kirsten Nielsen, David B Meya, David R Boulware, on behalf of ASTRO-CM Study Team

    2015

  • Delta-like 1 protein, vitamin D binding protein, and fetuin measurement in cerebrospinal fluid for detection of Mycobacterium tuberculosis meningitis.

    Nathan C Bahr, Ryan Halupnick, Grace Linder, Reuben Kiggundu, Henry W Nabeta, Darlisha Williams, Srinand Srevatsan, Joshua Rhein, David B Meya, David R Boulware

    2015

  • Interleukin-6, Tumor Necrosis Factor-α Expression and Monocyte Subset Phenotype are Associated with Cryptococcal Immune Reconstitution Inflammatory Syndrome

    Meya DB, Okurut S, Zziwa G, Cose S, Bohjanen P, Mayanja-Kizza H, Joloba M, Palmer B, Boulware DR, Manabe YC, Wahl SM, Janoff EN

    2015

  • Characteristics and outcomes of patients seeking care at a new “co-pay” convenience clinic established to explore sustainable funding models in Uganda

    Rosalind Parkes-Ratanshi; Andrew Kambugu, Gerald Mukisa; Tom Kakaire; Faridah Mayanja; Adelline Tumikye; Brenda Mitchell; Shadia Nakalema; Walter Schlech

    2015

  • Gene Xpert MTB/Rif for use in detection of meningitis due to Mycobacterium tuberculosis: a prospective trial

    Nathan C Bahr, Lillian Tugume, Radha Rajasingham, Reuben Kiggundu, Darlisha A Williams Danielle Amisano, David Alland, David B Meya, Joshua Rhein, David R Boulware

    2015

  • Delta-like 1 ligand (DLL1), vitamin D binding protein (VDBP), and fetuin in cerebrospinal fluid for detection of Mycobacterium tuberculosis meningitis

    Nathan C Bahr, Ryan Halupnick, Grace Linder, Reuben Kiggundu, Henry W Nabeta, Darlisha Williams, David B Meya , Srinand Sreevatsan, Joshua Rhein , David R Boulware

    2015

  • Ten Years Outcomes In A Cohort Of Patients Started On Antiretroviral Treatment In An Urban Clinic In Sub-Saharan Africa

    Castelnuovo B, Nyakato P, Musaazi J, Mubiru F, Kambugu A, Kamya M, Kiragga An

    2014

  • Monitoring Antiretroviral Therapy In Uganda: Budget Impact Analysis Of Two Strategies For Viral Load Monitoring Versus Immunologic Monitoring. PIN 22

    Castelnuovo B, Parkes-Ratanshi R, Kakaire T, Sempa J, Reynolds S, Lamorde M

    2014

  • Diagnostic Performance of a Multiplex PCR Assay for Meningitis In an HIV-Infected Population In Uganda

    Joshua Rhein, Joann L Cloud, Andrew C Hemmert, Nathan C Bahr, Satya Bellamkonda, Cody Oswald, Eric Lo, Henry W Nabeta, Reuben Kiggundu, Andrew Akampurira, Darlisha Williams, David B Meya, David R Boulware

    2014

  • Detection of High CSF Level of (1-3) – Beta-D-glucan In Cryptococcal Meningitis

    Joshua Rhein, Nathan C Bahr, Bozena Morawski, Charlotte Schutz, Yonglong Zhang, Malcolm Finkelman, David B Meya, Graeme Meintjes, David R Boulware

    2014

  • Boosted Lopinavir vs boosted Atazanavir in patients failing an NNRTI first line regimen in an urban clinic in Kampala

    Laker Eva, Mambule Ivan;Nalwanga Damalie ;Sekaggya Christine ;Musaazi Joseph; Kiragga Agnes ;Parkes-Ratanshi Rosalind

    2014

  • The Cost-Effectiveness Of Antenatal Syphilis Screening Using Point-Of-Care Testing In Low And Middle Income Countries In Asia.

    Christine Muhumuza, Henry Komakech, Mohammed Lamorde, Elsa Marques, Andreas Kuznik

    2014

  • The Cost-Effectiveness Of Antenatal Syphilis Screening Using Point-Of-Care Testing In Latin America

    Henry Komakech, Christina Muhumuza, Mohammed Lamorde, Elsa Marques, Andreas Kuznik.

    2014

  • Cost Of Patient Care At Different Stages Of Treatment Within The Public Health Model Of Hiv Care; Analysis From An Urban Hiv Centre In Uganda

    Rosalind Parkes-Ratanshi, Tom Kakaire, Joseph Sempa, Benneth Musiime, Andreas Kuznik2, Barbara Castelnuovo, Walter Schlech

    2014

  • Engaging traditional health practitioners in the early detection of Kaposi’s sarcoma in Uganda

    Lisa M. Butler, Miriam O.Laker-Oketta, Philippa Kandam-Makanga, Joseph Baguma & Jeffrey N. Martin

    2014

  • Delayed Diagnosis of HIV-Associated Kaposi sarcoma in Uganda: A Qualitative Analysis

    Erin Amerson, Amy Forrestel, Lisa Butler. Miriam Laker-Oketta, Mwebesa, Toby Maurer, and Jeffrey Martin

    2014

  • Low olevel of Kaposis Sarcoma Specific Knowledge & Screening Practices among clinicians in Uganda

    Miriam Laker-Oketta, Megan Wenger, Lisa Butler, Philippa Makanga, Toby Maurer, Edward Mbidde & Jeffrey Martin

    2014

  • Task-shifting & skin punch for the histologic Diagnosis of Kaposi’s sarcoma: A public Health Solution to a public Health problem.

    Miriam Laker-Oketta, Megan Wegner, Aggrey Semeere, Barbara Castelnuovo, Andrew Kambugu, Robert Lukande, F Chite Asirwa, Naftali Busakhala, Nathan Buziba, Kara Wools Kaloustian, Constantin Yiannoutsos, Mwebesa Bwana, Winnie Muyindike, Erin Amerson,Edward Mbidde, Toby Mauer, & Jeffrey Martin

    2014

  • . Effect of food on the steady-state pharmacokinetics of rilpivirine when administered as a fixed-dose combination in HIV-1 infected Ugandan adults

    Lamorde M, Walimbwa S, Byakika-Kibwika P, Michael Katwere, Lillian Mukisa, Joseph Sempa, Laura Else, Back D, Khoo S, Merry C

    2014

  • Non-invasive Assessment of Intracranial Pressure in Cryptococcal Meningitis using Tonometry or Ocular Ultrasound

    Henry Nabeta, Nathan Bahr, Nicholas Fossland, Joshua Rhein, Agnes Kiragga, David B Meya, Stephen J Dunlop, David R Boulware

    2014

  • Detection of High CSF Levels of (1→3)-Beta-D-glucan in Cryptococcal Meningitis

    Joshua Rhein, Nathan C. Bahr, Bozena Morawski, Charlotte Schutz, Yonglong Zhang, Malcolm Finkelman, David B. Meya, Graeme Meintjes, David R. Boulware.

    2014

  • Effect of Adjunctive Sertraline on QTc Interval in Patients with Cryptococcal Meningitis

    Sruti S Velamakanni, Reuben Kiggundu, Joshua Rhein, Elissa Butler, David B Meya, David R Boulware

    2014

  • Impact of Antiretroviral Therapy on Kaposi’s Sarcoma Incidence Among HIV-Infected Adults in East Africa

    Aggrey Semeere, Megan Wenger, Naftali Busakhala, Nathan Buziba, Mwebesa Bwana, Winnie Muyindike, Erin Amerson, Toby Maurer, Beverly Musick, Constantin Yiannoutsos, Robert Lukande, Barbara Castelnuovo, Andrew Kambugu, David Glidden, Eric Vittinghoff , Kara Wools-Kaloustian, and Jeffrey Martin

    2014

  • Loss to program in pre-antiretroviral treatment care in a large urban clinic in Uganda 2.

    Castelnuovo B, Musomba R, Musaazi J, Kambugu A, Kiragga A.

    2014

  • Serum Biomarkers Following Induction Therapy for Cryptococcal Meningitis Predict Survival

    Joshua Rhein, James Scriven, Kathy Huppler Hullsiek, Maximilian von Hohenberg, David B Meya, Conrad Muzoora, Graeme Meinjtes, David R Boulware

    2014

  • Cost-savings of viral load testing before ART second line switch in a resource limited setting.

    Kigozi J, Mugasha C, Muganzi A, Coutinho A, Manabe YC

    2014

  • The role of Treatment Buddies in Mediating the Relationship between HIV Treatment Adherence, Mortality and time to first switch of ART

    Jane Wanyama, Bonnie Wandera, Agnes Kiragga, Daniel Kasibante, Rosalind Parkes R, Barbara Castelnuovo

    2013

  • The Impact of Antiretroviral therapy on Kaposi Sarcoma incidence among HIV infected adults in East Africa.

    Aggrey Semeere1,2 , Megan Wenger , Naftali Busakhala3 , Nathan Buziba4, Mwebesa Bwana4, Winnie Muyindike4, Erin Amerson2, Toby Maurer2, Berverly Musick5, Constantin Yiannoutsos5, Robert Lukande6,Barbara Castelnuovo1, Andrew Kambugu1, David Glidden2, Eric Vittinghoff2,Kara Wools-Kaloustian5, and Jeffrey Martin

    2013

  • The Effect of Therapeutic Lumbar Punctures on Acute Mortality from Cryptococcal Meningitis

    Melissa A Rolfes, Joshua Rhein, Katherine Huppler Hullsiek1, Henry Nabeta, Kabanda Taseera, Charlotte Schutz, Radha Rajasingham, Darlisha A Williams, David Meya, Conrad Muzoora, Graeme Meintjes and David Boulware

  • Engaging Traditional Health Practitioners in the Early Detection of Kaposi’s Sarcoma in Uganda

    Lisa M. Butler, Miriam O. Laker-Oketta, Philippa Kadama-Makanga, Joseph Baguma, and Jeffrey N. Martin.

    2013

  • Antiretrovirals for Kaposi’s Sarcoma (ARKS): A randomized trial of protease inhibitor-based antiretroviral therapy for AIDS-associated Kaposi’s sarcoma in sub-Saharan Africa.

    Jeffrey Martin, Miriam Laker-Oketta, Victoria Walusana, Jackson Orem, Henry Wabinga, John Bennett, Adrienne Mocello, Megan Wenger, Toby Maurer, Peter Hunt, Andrew Kambugu, and Edward Mbidde

    2013

  • Low Level of Kaposi’s Sarcoma-Specific Knowledge and Screening Practices among Clinicians in Uganda.

    Miriam Laker-Oketta, Megan Wenger, Lisa Butler, Philippa Makanga, Toby Maurer, Edward Mbidde, and Jeffrey Martin

    2013

  • Denning. Estimated burden of fungal disease in Uganda.

    R. Parkes-Ratanshi, B. Achan, A. Kambugu, D. Meya, D

    2013

  • Determinants of Utilization of a No-Cost HIV Transition Clinic: A Cross Sectional Study of Young Adults Living with HIV/AIDS in Uganda.

    Agnes Nyabigambo, Joshua Kanaabi Muliira, Lynn Atuyambe, Harriet Babikako, Andrew Kambugu, Christopher Ndoleriire

    2013

  • Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda

    Joseph Sempa, Mark Ssennono, Andreas Kuznik, Mohammed Lamorde, Stefanie Sowinski, Aggrey Semeere, Sabine Hermans, Barbara Castelnuovo, Yukari C. Manabe

    2013

  • Sexual and Reproductive Health In HIV-positive young women in an Urban Clinic in Uganda; Causes of Vaginal discharge.

    C. Katusiime, A. Kambugu, W. Schlech, R. Parkes-Ratanshi

    2013

  • A study of the potential benefit of integration of quality sexual and reproductive health (SRH) with HIV care using a “stepped wedge” design

    Christine Katusiime, Walter F Schlech, Jolly Beyeza-Kashesya, Rosalind Parkes

    2013

  • Sexual and reproductive health in young people with HIV in an urban clinic in Uganda: the important role of syphilis

    Christine Katusiime, Andrew Kambugu, Walter F Schlech, R Parkes-Ratanshi

    2013

  • Mycobacteremia and Associated Mortality among HIV-infected smear negative Tuberculosis Suspects in Uganda

    Lydia Nakiyingi, W Ssengooba, O Mbabazi, J Sempa, D Armstrong, M.Holshouser, ML. Joloba, JJ Ellner, SE Dorman3, YC Manabe

    2013

  • Early Antiretroviral Therapy after Cryptococcal Meningitis is associated with Worse 26-week Survival.

    Boulware DR, Meya DB, Muzoora C, Rolfes MAR, Huppler Hullsiek K, Taseera K, Musubire A, Nabeta HW, Schutz C, Williams DA, Rajasingham R, Lo MW, Rhein J, Kambugu A, Bohjanen PR, Meintjes G, and the COAT Team

    2013

  • HIV-pathogen interaction and the Immune Reconstitution Inflammatory Syndrome

    William Worodria

    2012

  • Cost-effectiveness of HIV prevention strategies in Uganda

    Joseph Bukulu Sempa, Mohammed Lamorde, Mark Ssennono, Andreas Kuznik, Yuka Manabe, Barbara Castelnuovo, Andrew Kambugu

    2012

  • Constitutional symptoms and HIV severity influence clinicians’ decision to treat tuberculosis in sputum smear negative HIV-infected tuberculosis suspects in Uganda

    L. Nakiyingi, J. Sempa, C. Katabira, Y. Manabe

    2012

  • Merry Efavirenz and nevirapine significantly affect artemether-lumefantrine pharmacokinetic exposure in HIV-Infected Ugandan adults

    P. Byakika-Kibwika, M. Lamorde, H. Mayanja-Kizza, E. Katabira, S. Khoo, D. Back, N. Lindegardh, J. Tarning, P.J. de Vries, C

    2012

  • Diagnosing Kaposi Sarcoma(KS) in East Africa: How accurate are clinicians and Pathologists?

    Miriam Laker

    2012

  • Baseline Mapping Survey of decentralised ART Service Provision in Uganda

    Ivan Mambule, Lablite

    2012

  • HIV Viremia copy-years independently predict mortality in HIV-infected patients initiated on antiretroviral therapy in a resource-limited setting.

    Joseph B. Sempa, Agnes N. Kiragga, Barbara Castelnuovo, Sabine M. Hermans, Moses R Kamya, Yukari C. Manabe

    2012

  • Implementation and results of real time provider entry electronic medical records in a large HIV program in Sub-Saharan Africa.

    Barbara Castelnuovo, Victor Afayo, Malisa Ncube, Richard Orama, and Agnes N Kiragga

    2012

  • CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre

    Agnes N. Kiragga, Beverly Musick , Ann Mwangi, Constantin T. Yiannoutsos

    2012

  • Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.

    Sabine M Hermans, Yukari C Manabe, Agnes N Kiragga, Andy IM Hoepelman, Joep MA Lange, Frank van Leth

    2012

  • Quantifying the Financial and Disease Burden Associated with Mother to Child Transmission of HIV in Uganda.

    1. A. Kuznik, A. Semeere, J. Sempa, B. Auerbach, M. Lamorde, B. Castelnuovo, S. Hermans, F. Ssewankambo, M. Ssennono, L. Mpanga Sebuyira, Y.C. Manabe

    2011

  • Cost-Effectiveness of Earlier Initiation of First Line Combination Antiretroviral Therapy in an Urban Outpatient HIV Clinic in Uganda.

    A. Kuznik, J. Sempa, M. Ssennono, S. Hermans, B. Castelnuovo, M. Lamorde, A. Semeere, B. Auerbach, S. Sowinski, F. Ssewankambo, Y.C. Manabe

    2011

  • Cost-Effectiveness of Rifampicin-Based Continuation Phase of Tuberculosis Treatment in Uganda

    A. Kuznik, S. Hermans, B. Castelnuovo, B. Auerbach, F. Ssewankambo, J. Sempa, M. Ssennono, M. Lamorde, A. Semeere, Y.C. Manabe

    2011

  • Cost-Effectiveness of the New Guidelines for the Prevention of Mother to Child Transmission of HIV in Uganda. Value in Health – November 2011 (Vol. 14, Issue 7, Page A275, DOI: 10.1016/j.jval.2011.08.243

    A. Kuznik, M. Lamorde, A. Semeere, B. Castelnuovo, S. Hermans, B. Auerbach, F. Ssewankambo, M. Ssennono, J. Sempa, L. Mpanga Sebuyira, Y.C. Manabe

    2011

  • Oral presentation on ‘T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort’

    Damalie Nakanjako

    2011

  • Steady-state exposure of ritonavir is reduced by a high fat meal in Ugandan patients receiving lopinavir plus ritonavir co-formulated tablets.

    Lamorde M, Byakika-Kibwika P, Nabukeera L, Amara A, Hughes A, Ryan M, Ogwal-Okeng J, Boffito M, Back D, Khoo S, Merry C

    2011

  • Unfavorable Pharmacokinetic Interaction between Artemether/lumefantrine and Rifampin-Based Tuberculosis Treatment.

    M. Lamorde, P. Byakika-Kibwika, J. Mayito, M. Ryan, W. Hanpithakpong, N. Lindegardh, S. Khoo, D. Back, C. Merry

    2011

  • Integration of HIV and TB services results in earlier and more prioritised ART initiation in Uganda

    Sabine Hermans, Barbara Castelnuovo, Andrew Kambugu, Joep Lange, Andy Hoepelman, Yuka Manabe

    2011

  • The uptake of antenatal syphilis screening and prevalence of syphilis among HIV- infected pregnant women at the Infectious Diseases Institute- Uganda

    Namale Gertrude, Fred Sewankambo, Andrew Kambugu, Nadine Pakker, Yukari C. Manabe

    2011

  • High-risk Sexual Behavior Persist among Young PLHIV Despite Heightened HIV Prevention Awareness at an Urban HIV Clinic in Uganda

    Julian Nkurayija, Timothy R Muwonge, Fred Ssewankambo, Andrew Kambugu

    2011

  • Low HIV sero-conversion rates among HIV discordant couples attending a large urban HIV clinic in Uganda.

    T. Muwonge, F. Namimbi, P. Bakabulindi, L. Wakabi, S. Weguli, A. Kambugu

    2011

  • Minimal food effect on steady-state pharmacokinetics of lopinavir when administered as a tablet formulation in Ugandan HIV- positive patients.

    M. Lamorde, P. Byakika-Kibwika, L. Nabukeera, A. Amara, A. Hughes, J. Tjia, M. Boffito, S. Khoo, D. Back, C. Merry

    2011

  • Factors determining contraceptive use among HIV-infected women attending HIV/AIDS care in an urban center

    F. Ssewankambo, R. Ayanga, E. Nalintya, S. Wejuli, J. Sempa, A. Kambugu

    2011

  • Demographic data and treatment outcomes of HIV positive patients on ART aged 50 and above at the Adult Infectious Diseases Clinic, Kampala.

    Aggrey S. Semeere, Sujal Parikh Joseph Sempa, Isaac Lwanga, Robert Cumming, Harriet Mayanja-Kizza

    2011

  • Patients with sustained viral suppression after 2 years on ART experience long term progressive immune reconstitution regardless of the CD4+ count at antiretroviral treatment star.

    Joseph B. Sempa, Barbara Castelnuovo, Agnes N. Kiragga , Moses R Kamya, Yukari C. Manabe

    2011

  • TUPE472 titled “Evaluation of the impact of TB-HIV integrated care in reducing the proportion of patients defaulting anti TB treatment in a large urban HIV clinic in Kampala, Uganda”

    Castelnuovo, Barbara

    2011

  • Reason for changing antiretroviral treatment before and after implementation of the 2006 WHO guidelines.

    Barbara Castelnuovo, Agnes Kiragga, Joseph B Sempa and Yukari Manabe

    2011

  • Trends and frequency of CD4+ cell count among patients on ART in a large HIV observational database in resource limited settings

    Agnes N Kiragga, Barbara Castelnuovo, Joseph B Sempa, Yukari C Manabe

    2011

  • Patients with sustained viral suppression after 2 years on ART experience long term progressive immune reconstitution regardless of the CD4+ count at antiretroviral treatment start.

    Joseph B. Sempa, Barbara Castelnuovo, Agnes N. Kiragga, Moses R Kamya, Yukari C. Manabe

    2011

  • Special Issues concerning HIV Infected Adolescents and Young People, National ART Sub Committee for the Uganda Integrated Guidelines for HIV Care in Adults, Adolescents and Children,31st March 2011,Kampala,Uganda

    Bakeera-Kitaka, Sabrina

    2011

  • The HIV positive Male Adolescent,2nd Adolescent Health Workshop, A collaboration between Makerere University and Columbia University, March 22-23, 2011,Kampla,Uganda

    Bakeera-Kitaka, Sabrina

    2010

  • High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort

    Damalie Nakanjako, Isaac Ssewanyana, Harriet Mayanja-Kizza, Agnes Kiragga, Robert Colebunders, Yukari C. Manabe, Rose Nabatanzi, Moses R. Kamya, Huyen Cao

    2011

  • CD4+ T-cell Recovery after ART in HIV-TB Co-infected Patients is Blunted in Patients with ART-associated TB Compared to Patients with TB Treated Prior to ART

    Sabine M. Hermans, Frank van Leth, Agnes Kiragga, Andy I.M. Hoepelman, Joep M.A. Lange, Yukari C. Manabe

    2011

  • Overview of clinical pharmacology research at the IDI

    Mohammed, Lamorde

    2010

  • Accuracy of an ‘In-house’ sputum polymerase chain reaction assay for rapid diagnosis of sputum smear negative pulmonary TB at Mulago hospital, Uganda.

    L. Nakiyingi, P. Ocama , D. Kateera, B. Asiimwe, F. Katabazi, A. Katamba, M. Joloba, H. Mayanja-Kizza

    2010

  • Multi-media educational tool (speaking book) increases knowledge of clinical trials among HIV-positive patients in Kampala, Uganda

    Robertson G, Rasmussen S, Hubbard R, Newell K, Denty M, Manabe Y

    2010

  • Alcohol use, hepatotoxicity and liver disease in an ART program in Southwestern Uganda

    L Stabinski, K Opio, E Seremba, P Ocama, V Kiggundu, R Gray et al

    2010

  • Patients on ART in resource limited settings with episodes of intermediate viremia (1,001-10,000 copies/ml) are at risk of impaired immune-reconstitution and treatment failure

    Barbara Castelnuovo, Joseph Sempa, Kiragga Agnes, Moses Kamya, and Yukari Manabe

    2010

  • Perspectives in transition,” Knowledge, attitudes and practices of young people regarding HIV positive prevention in an urban HIV clinic in Uganda: A mixed methods study

    Agnes Nanyonjo, Christine Kihembo, Timothy Muwonge, Andrew Kambugu, Sabrina Bakeera- Kitaka

    2010

  • HIV patients on antiretroviral treatment diagnosed with smear positive tuberculosis and smear negative/extra-pulmonary have similar mortality rates.

    Joseph B Sempa, B. Castelnuovo, A. Kiragga, Yuka M

    2010

  • Pregnancy Intention and Pregnancy Risk Behavior Among Women Receiving HIV/AIDS Care in Uganda

    Fred Ssewankambo, Carol Nalugwa, Ibrahim Lutalo, Andrew Kambugu

    2010

  • Progressive normalization of liver enzyme elevation during the first 30 months of ART in an HIV positive patient cohort in Uganda.

    Ponsiano Ocama, Barbara Castelnuovo, Agnes Kiragga, Steve J Reynolds Moses R Kamya, Robert Colebunders, David L. Thomas

    2010

  • Integrating Family Planning (FP) in HIV/AIDS Care Model: AIDC in Uganda

    ssewankambo, Fred

    2010

  • Sub-optimal nevirapine concentrations during intrapartum compared with postpartum in HIV-1 infected Ugandan women.

    Lamorde M, Byakika-Kibwika P, Kayom VO, Kalemeera F, Flaherty J, Boffito M, Ryan M, Merry C, Scarsi K

    2010

  • Medication refill adherence and viral rebound in a cohort of HIV-infected Ugandan adults in the 2nd year of antiretroviral therapy.

    Lamorde M, Byakika P, Kiragga A, Castelnuovo B, Ncube M, Babigumira J, Lubwama E, Stergarchis A, Merry C

    2010

  • Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.

    Hermans SM, Kiragga A, Schaefer P, Kambugu A, Hoepelman AIM, Manabe YC

    2010

  • Effect of the duration of antiretroviral therapy on the CD4 count at tuberculosis diagnosis in patients from a large urban clinic in Sub-Saharan Africa.

    Petra Schaefer, Barbara Castelnuovo, Kathy Baisley, Sabine Hermans, Yuka Manabe

    2010

  • WHO Immunologic criteria are more predictive of treatment failure in patients from a Western Cohort compared to a cohort in Resource Limited Settings

    Kiragga Agnes, Castelnuovo Barbara, Kamya Moses, Moore Richard, Manabe C Yukari

    2010

  • Increased Baseline CD4-count at ART Initiation Improves Survival and Leads to Decreased Incidence of Tuberculosis in an Urban HIV Clinic in Sub-Saharan Africa.

    Sabine M Hermans, Yukari C Manabe, Andy IM Hoepelman, Andrew Kambugu

    2010

  • MRNA Biomarkers of CD4 Immune Recovery with Antiretroviral Therapy in persons with AIDS in Sub-Saharan Africa.

    David R. Boulware, Tracy L. Bergemann, David B. Meya MBChB, Darin Wiesner, Andrew Kambugu, Edward N. Janoff, Paul R. Bohjanen

    2010

  • Nevirapine plasma concentrations during initiation with 200 mg versus 400 mg daily in HIV/TB co-infected adults on rifampicin.

    Lamorde M, Byakika-Kibwika P, Kayom VO, Kalemeera F, Namakula R, Boffito M, Ryan M, Colebunders R, Back DJ, Khoo S, Merry C.

    2010

  • Sexual behavior of HIV-positive persons before and after one year of Antiretroviral therapy at the Infectious Diseases Clinic, Kampala, Uganda.

    Wanyama J, Kasibante D, Kayiira P, Wandera B, Kambugu A

    2010

  • Sexual behavior of HIV-positive persons before and after one year of Antiretroviral therapy at the Infectious Diseases Clinic, Kampala, Uganda.

    Wanyama, Jane: Kasibante,Daniel: Kayiira,Prossy: Wandera, Bonnie: Kambugu, Andreww

    2009

  • Examining drug default for treatment of tuberculosis in an urban HIV clinic in Uganda

    Katabira C, Castelnuovo B, Bhushan A, Lee E, Kambugu A, Manabe Y

    2009

  • Toxicity to fixed dose stavudine, lamivudine and nevirapine in Uganda is very high but not associated with increased virologic failure

    Semitala F, Kiragga A, Castelnuovo B, Kambugu A, Kalyesubula R, Mayanja- Kizza H, McAdam K, Schlech W, Colebunders R, Kamya M

    2009

  • Sexual behaviour of HIV infected patients on antiretroviral therapy (ART) in an urban HIV clinic in Kampala Uganda: a 3-year follow-up study.

    B. Wandera, Sethi A, Easterbrook P, Castelnuovo B, Kiragga A, Whalen C, Kambugu A, Kamya M

    2009

  • Clinical and immunological outcomes of second line treatment delivered in a routine clinical setting in Uganda.

    Kiragga A, B. Castelnuovo, I. Mambule, A. Kambugu, Y. Manabe

    2009

  • Barriers to ARV Therapy Adherence in a Cohort of Adolescents in Urban Uganda.

    Bakeera-Kitaka S, Angevine R, Dillingham R, Kekitiinwa A

    2009

  • Very low rates of abacavir hypersensitivity reactions among African children in the ARROW (AntiRetroviral Research fOr Watoto) trial

    Nahirya P, Naidoo B, Kekitiinwa A, Spyer M, Kasirye P, Bakeera – Kitaka S, Crawley J

    2009

  • Pharmacokinetics of Once versus Twice Daily Lamivudine and Abacavir in HIV-1 Infected Ugandan Children in the ARROW trial.

    Musiime V, Ferrier A, Bakeera – Kitaka S, Odongo F, Kekitiinwa A, Thomason M, Lee D, Burger D, Thoofer N, Nahirya Ntege P, Nathoo K, Snowden W, Musoke P, Mugyenyi P, Walker A

    2009

  • High rate of misclassification of treatment failure based on WHO immunological criteria in resource limited settings (Uganda)

    Kiragga A, Schaefer P, Kambugu A, and Castelnuovo B

    2009

  • The use of efavirenz is associated with a decreased incidence of tuberculosis after antiretroviral therapy initiation in an urban HIV clinic in sub-Saharan Africa

    Hermans SM, Kiragga A, Schaefer P, Kambugu A, Hoepelman IM, Manabe YM

    2009

  • Sexually Transmitted Infections and family Planning usage among Young Adults accessing care at Infectious Diseases Institute (IDI), Mulago Kampala, Uganda

    Muwonge T, Bakeera-Kitaka S, Nkuraija J, Lutalo I, Matovu E, Kambugu A.

    2009

  • Sexually Transmitted Infection (STI) symptom prevalence, knowledge, disclosure and treatment seeking behaviours amongst discordant couples at the Infectious Diseases Institute

    Matovu E, Birabwa E, Muwonge T, Lutalo I, Kambugu A.

    2009

  • Reliability of Reporting of Recent Sexual Activity within Couples

    G.B. Robertson, G. de Bruyn, K. Newell, A. Kiragga, J.A. McIntyre, G.E. Gray

    2009

  • Predictors of Pregnancy Among HIV-Positive Women attending an Urban HIV-Care Center

    Fred Ssewankambo, Evelyn Nabankema, Justine Walusimbi, Agnes Nanyonjo, Ibrahim Lutalo, Andrew Kambugu

    2009

  • Cost effectiveness of Serum Cryptococcal antigen (CRAG) screening to Prevent Death in HIV- infected persons with CD4 <100/μL in sub-Saharan Africa. Oral

    David B Meya, Barbara Castelnuovo, Andrew Kambugu, Yukari C Manabe, Moses Kamya, Paul Bohjanen, David R Boulware

    2009

  • Stavudine toxicity is the main reason for treatment change in women in a prospective cohort of patients started on first line antiretroviral treatment (ART) in Uganda

    B Castelnuovo, Kiragga A, Kamya M, Manabe Y

    2009

  • Factors associated with increasing HIV-1 resistance to antiretroviral therapy in an urban cohort in Kampala, Uganda

    Hakim Sendagire, Barbara Castelnuovo, Agnes Kiragga, Andrew Kambugu, Moses Kamya, Philippa Easterbrook, Yuka Manabe, Eric Art, T

    2009

  • Health Control Beliefs, Risk Behaviour and HIV-serostatus in Soweto, South Africa

    G.B. Robertson, G. de Bruyn, K. Newell, J. Menten, A. Kiragga, J.A. McIntyre, G.E. Gray

    2009

  • Gene expression biomarkers in blood predict cryptococcal immune reconstitution inflammatory syndrome

    David Boulware, David Meya, Tracy Bergemann, Joshua Rhein, Darin Wiesne, Darlisha Williams, Irina Vlasova, Andrew Kambugu, Edward Janof, Paul Bohjanen

    2009

  • Low incidence of liver enzyme elevation in HIV infected patients attending a large Urban treatment Center in Kampala, Uganda

    Ocama P, Castelnuovo B, Kamya M, Kirk G, Reynolds S, Kiragga A, Thomas D, Lee W, Colebunders R

    2009

  • Reasons for treatment change in a 3 year prospective cohort of patients started on first line antiretroviral treatment in Uganda

    Castelnuovo B, Kiragga A, Kamya M, Manabe Y

    2009

  • More advanced disease at ART initiation and high death rate from OIs explain higher mortality among African patients initiating antiretroviral therapy (ART) in Uganda compared to London

    Philippa Easterbrook, Fowzia Ibrahim, Agnes Kiragga, Barbara Castelnuovo, Andrew Kambugu, Moses Kamya

    2009

  • Serum Inflammatory Biomarkers Predict HIV Immune Reconstitution Inflammatory Syndrome and Death after Cryptococcal Meningitis

    Boulware D, Meya D, Bergemann T, Shuli B, Kambugu A, Janoff E, Bohjanen P

    2009

  • Reconstitution Inflammatory Syndrome (KS-IRIS) In Africa: Initial Findings From A Prospective Evaluation (oral presentation)

    Martin J, Laker M, Clutter D, Kambugu A, Orem J, Janka D, Bennett J, Deeks S, Maurer T, Mbidde E.K.: Kaposi’s Sarcoma-Associated Immune

    2009

  • Risk Factors for Severe Anemia after Initiation of ART in Urban Uganda

    Kiragga A, Castelnuovo B, Nakanjako D, Manabe Y

    2009

  • Determinants of contraceptive use among HIV infected women attend care in an urban center

    Sewankambo F, Nalugwa C, Namale G, Lutalo I

    2009

  • Sexually Transmitted Infection (STI) frequency and challenges of using family planning among discordant couples at AIDC

    Birabwa E, Matovu E, Kihembo C, Lutalo I, Kambugu A

    2009

  • Initiating Antiretroviral Therapy at CD4 Counts Below 350 cells/ µl. What Does This Mean To HIV/AIDS Care Programs In Uganda?

    Nakanjako D, Kiragga A, Castelnuovo B, Kambugu A, Munabe Y

    2009

  • Integrating Tuberculosis (TB) Screening and HIV/AIDS Care Improves Diagnosis of TB-HIV Co-infections At An Urban Public HIV Clinic In Uganda

    Nakanjako D, Mayanja-Kizza H, Ouma J, Wanyenze R, Mwesigire D, Namale A, Ssempiira J, Senkusu J, Colebunders R and Kamya MR

    2009

  • Factors associated with pregnancy intentions among women receiving HIV/AIDS Care in Uganda

    Sewankambo F, Nalugwa C, Lutalo I, Kambugu A.

    2009

  • Traditional medicine use in the context of antiretroviral therapy in Uganda.

    M. Lamorde, P. Waako, J. Tabuti, C. Obua, H. Lanyero, C. Kukunda, G. Bbosa, P. Byakika-Kibwika, F. Kalemeera, M. Ryan, C. Merry

    2009

  • Sharing experiences and optimizing south-to-south collaboration in preparing resource limited sites for vaccine trials: The TB Vaccine sites.

    Wajja A, Nabongo P, Bakeera-Kitaka S, Musoke P, Mayanja-Kizza H

    2009

  • Clinical pharmacology for Global Health, a North – South – South partnership

    M Lamorde, P Byakika-Kibwika, V Okaba, F Kalemeera, M Ryan, C Hughes, J Feely, D Back, S Khoo, M Boffito, R Murphy, C Merry

    2009

  • Irish post-graduate training supports a multi-disciplinary health team in Africa to confront HIV/AIDS, tuberculosis and malaria

    Merry C, Lamorde M, Byakika-Kibwika P, Kalemeera F, Ryan M, Hughes C, Kennedy J, Kelleher D, Feely J

    2008

  • The Workforce and Cost Implications of Substituting Nurses and Pharmacists for Doctors in the Follow-up of Patients with AIDS on Antiretroviral Therapy in Uganda

    J.B. Babigumira, B. Castelnuovo, M. Lamorde, A. Muwanga, A. Kambugu, P. Easterbrook, L.P. Garrison

    2008

  • Clinical presentation of epidemic kaposi’s sarcoma differs by gender in kampala, Uganda

    Phipps Wp1, Nguyen Hq1, Ssewankambo F2, Cattamanchi A1, Wald A1, Corey L1, Orem J3, Kambugu A2, Casper C

    2008

  • Clinical manifestations and cytokine profiles in HIV-infected Ugandan patients who develop immune reconstitution inflammatory syndrome (IRIS)

    Boulware D. R, Meya D, Bonham S, Janoff E. N, Kambugu A, Bohjanen P. R

    2008

  • On-going sexual transmission of HBV infection among the highly susceptible adult population of Rakai, Uganda.

    Stabinski, L., Reynolds, S.R., Ocama, P., Serwadda, D., Quinn, T., Thomas, D.L., Gray, R. and Kirk, G.D.

    2008

  • Hepatitis C seroprevance among HIV positive and HIV-negative patients in Kampala, Uganda.

    Reilly, J., Ocama, P., Opio, K., Andama, A. and Sofair, A

    2008

  • Patterns and predictors of suboptimal CD4 reconstitution among patients with viral suppression in an urban cohort initiating antiretroviral therapy in sub-Saharan Africa.

    Nakanjako, D., Kiragga, A., Ibrahim, F., Castelnuovo, B., Kamya, M. and P, E

    2008

  • Removing the obstacles towards timely diagnosis of kaposi’s sarcoma in sub-saharan africa: use of simple equipment and easier patient access to hasten the performance of biopsies.

    Laker, M.O., Kambugu, A., Kiirya, M., Phillips, A., Janka, D., Orem, J., Wabinga, H., Maurer, T., Katongole-Mbidde, E. and Martin, J

    2008

  • Severe sepsis in two Ugandan hospitals: a prospective study evaluating the management and outcomes of a predominantly HIV-1 infected population.

    Jacob, S., Moore, C., Banura, P., Pinkerton, R., Meya, D., Opendi, P., Reynolds, S., Kenya-Mugisha, N., Mayanja-Kizza, H. and Scheld, W.

    2008

  • Microarray-based analysis of immune activation in AIDS patients in Sub-Saharan Africa before and after initiation of antiretroviral therapy.

    Boulware, D.R., Bergemann, T.L., Meya, D.B., Williams, D., Vlasova, I.A., Okiring, E., Kambugu, A., Janoff, E.N. and Bohjanen, P.R

    2008

  • Clinical presentation of epidemic Kaposi’s Sarcoma differs by gender in Kampala, Uganda

    Phipps WP, Nguyen HQ, Ssewankambo F, Cattamanchi A, Wald A, Corey I, Orem J, Kambugu A, Casper C

    2008

  • Clinical significance of sub-optimal CD4 reconstitution despite viral suppression in an urban cohort initiating antiretroviral therapy in sub-Saharan Africa.

    Nakanjako D, Kiragga A, Ibrahim F, Castelnuovo B, Kamya M.R

    2008

  • Steady-state pharmacokinetic comparison of generic and branded formulations of nevirapine, stavudine (d4T), and lamivudine (3TC) in HIV-infected Ugandan adults. Journal of Antimicrobial Chemotherapy

    Byakika-Kibwika P, Lamorde M, Kalemeera F, D'Avolio A, Mauro S, Di Perri G, Ryan M, Mayanja-Kizza H, Khoo S, Back D, Boffito M, Merry C

    2008

  • Clinical significance of sub-optimal CD4 reconstitution despite viral suppression in an urban cohort initiating antiretroviral therapy in sub-Saharan Africa

    Nakanjako D, Kiragga A, Ibrahim F, Castelnuovo B, Kamya M, Easterbrook P.

    2008

  • High rates of opportunistic infections (OIs) and mortality during first two years of ART in Uganda compared to African patients in London

    Ibrahim F, Kiragga A, Castelnuovo B, Kamya M, Easterbrook P

    2008

  • The Cost-Effectiveness of a Pharmacy-Only Refill Program in a Large Urban HIV/AIDS Clinic in Kampala, Uganda

    BJ, Castelnuovo B, Lamorde M, Obuku A E, Kiragga A, Schaefer P, Muwanga A, Kambugu A, Easterbrook P, Garrison LP

    2008

  • Validation of the quality of data collection in a large observational clinic database in Uganda using a nested research cohort.

    Kiragga A, Castelnuovo B, Kambugu A, Schaefer P, Kamya M, Easterbrook P

    2008

  • Hepatitis B infection in Special populations

    Ocama P

    2008

  • HIV subtype D is associated with a higher risk for dementia than subtype A in sub-Saharan Africa.

    Sacktor, N., Nakasujja, N., Rezapour, M., Skolasky, R., Musisi, S., Katabira, E., Robertson, K., Clifford, D., Laeyendecker, O., Quinn, T

    2008

  • Biomarkers of Immune Activation Are Predictors of HIV Immune Reconstitution Inflammatory Syndrome

    Boulware D, Meya D, Bergemann T, Vlasova I, Kambugu A, Janoff E, Bohjanen P

    2008

  • Lactate measurement of patients with suspected lactic acidosis with a hand-held analyzer in a large outpatient HIV clinic in Kampala, Uganda

    Kiragga A, Ocama P, Reynolds S, Ojiambo H, Castelnuovo B

    2008

  • Losses to follow-up in a large ART programme in Uganda

    Easterbrook P, Muwanga A, Schaefer P, Wandera M, Okello D, Castelnuovo B, Kamya M, Namale A, Kambugu A

    2008

  • Cause-specific mortality and contribution of Immune Reconstitution Inflammatory Syndrome (IRIS) during first two years of ART in Uganda

    Kambugu A, Castelnuovo B, Kiragga A, Kigonya C, Kamya M, Easterbrook P

    2008

  • Spectrum of liver diseases in HIV infected patients in East Africa

    Ocama, Ponsiano

    2007

  • Sexual Behavior of Persons on Antiretroviral Therapy With Improved Quality of Life

    Wanyama J, Nanyonjo A, Castelnuovo B, Wandera B, Kiragga A, Kambugu A, Kamya M.

    2007

  • Immune Reconstitution Inflammatory Syndrome and Post-Antiretroviral Tuberculosis among HIV-infected Ugandan Children.

    Kitaka S, Dhabangi A, Namulema E, Maganda A, Boulware D. R

    2007

  • Can response of Pruritic Papular Eruption (PPE) to highly active antiretroviral therapy (HAART) be used as a clinical parameter to predict virological outcome?

    Castelnuovo B, Byakwaga H, Menten J, Schaefer P, Kamya M, Colebunders R

    2007

  • Factors associated with a reduced CD4+ count response to highly active antiretroviral treatment in Sub-Saharan Africa

    Ssewankambo F, Wandera B, Castelnuovo B, Kamya M, Kambugu A, Kiragga A

    2007

  • Outcomes of Cryptococcal Meningitis in Sub-Saharan Africa in the Era of Antiretroviral Therapy (ART) Availability

    Kambugu A, Meya D. B, Rhein J, Boulware D, Lee A. S, Janoff E, Bohjanen P

    2007

  • Immune Reconstitution Inflammatory Syndrome in HIV Infected Ugandans

    Meya D B, Boulware D. R, Rhein J, Williams D, Lee S, Kambugu A, Janoff E. N, Bohjanen P

    2007

  • Use of Microarrays to Assess Immune Activation in HIV Immune Reconstitution Inflammatory Syndrome

    Boulware D. R, Meya, Bergemann T, Rhein J, Williams D, Vlasova I. A , Kambugu A, Janoff E. N, Bohjanen P. R

    2007

  • A need to integrate family planning services (FP) in HIV/AIDS care package for HIV positive women: a study at Infectious Diseases Institute (IDI)

    Nabankema E, Nanyonjo, A., Ssewankambo F., Muwanga A, Lutalo I, Walusimbi J., Anne Marie S, Kambugu A

    2007

  • Impact of an antiretroviral (ART) pharmacy refill program (PRP) in a resource constrained setting: experience at the infectious diseases institute (IDI) Uganda

    Obuku A.E, Lubwama E, Babigumira J, Castelnuovo B, Muganzi A M, Nanyonjo A, Obbo N, Lutalo R, Kiragga A, Lutalo I, Malisa N,Schaefer P, Muwanga A, Kambugu A, Stergachis A

    2007

  • Health Seeking Behavior for Sexually Transmitted Infections (STIs) amongst HIV Positive Female Patients and their spouses. Adult Infectious Diseases Clinic (AIDC) in Uganda

    Nanyonjo A, Nabankema E, Ssewankambo F, Lutalo I, Nakiwoga A, Mayanja F, Asscheman A,Schneider G, Kambugu A

    2007

  • Factors affecting condom use among HIV/AIDS women at a large urban HIV clinic in Kampala, Uganda

    Walusimbi J, Nabankema E , Lutalo I, Nakiwogga A, Nanjonjo A, Kihembo C, Schlech W, Kambugu A

    2007

  • Reinforcement of TB screening identifies a high burden of pulmonary tuberculosis among HIV/AIDS patients in the Mulago Immune Suppression Clinic, Uganda

    Nakanjako D, Mwesigire D, Wanyenze R, Ssempiira J, Ouma J, Senkusu J, Kamya M

    2007

  • High incidence of new opportunistic infections after starting antiretroviral treatment in Kampala, Uganda

    Castelnuovo B, Kiragga A, Wandera B, Kamya M

    2007

  • High incidence of symptomatic hyperlactemia in patients receiving stavudine: a case series from a resource limited setting, Uganda

    Castelnuovo B, Mwebaze P, Ocama P, Basenero A, Kambugu A

    2007

  • Assessing sexual risk reduction needs of adolescents living with HIV in a clinical care setting

    Bakeera - Kitaka S, Nabukeera - Brungi N, Noestlinger C, Kekitiinwa A, Colebunders B

    2007

  • Neurocognitive improvement with antiretroviral therapy among HIV positive individuals at the infectious diseases institute

    Noeline Nakasujja, Apollo Basenero, Ned Sacktor, Seggane Musisi, Richard Skolasky, Jeff Liner, Kevin Robertson, Allan Ronald, David Clifford and Elly Katabira

    2007

  • The evolution of patient knowledge on the cause and transmission of HIV after one year of HAART

    Wanyama J, Lutwama F, Kikaawa C, Wandera B, Castelnouvo B,Kambugu A, Kamya M

    2007

  • The impact of malnutrition on survival and immunological response in HIV infected patients starting antiretroviral therapy in Uganda

    Wandera B, Castelnuovo B, Kiragga A, Kambugu A, Mayanja Kizza H, McAdam K, Kamya M R

    2007

  • Failure of clinical and immunologic criteria to identify virologic failure in a resource limited setting (RLS): The Infectious Diseases Institute (IDI) Uganda experience

    Basenero A, Mwebaze P.S, Katwere M, Kalimugogo P, Birabwa E, John L, Prof. Keith M,Kambugu A, Prof.Walter F

    2007

  • 18 months follow up of second line lopinavir/ritonavir (LPV/r) containing therapy after failing first line non nucleoside reverse transcriptase inhibitor (NNRTI) containing regimens in a resource limited setting (RLS): a Ugandan experience

    Castelnuovo B, Lutwama F, Kambugu A

    2007

  • Antiretroviral Therapy in an Urban African Cohort does not prevent significant early mortality

    Kambugu A, Castelnuovo B, Wandera B, Kiragga A, Kamya M R

    2007

  • Immune Reconstitution Inflammatory Syndrome in HIV Infected Ugandans

    D. B. Meya , D. R. Boulware , J. Rhein, D. Williams, S. Lee, A. Kambugu, E. N. Janoff, P. R. Bohjanen

    2007

  • Can response of Pruritic Papular Eruption (PPE) to highly active antiretroviral therapy (HAART) be used as a clinical parameter to predict virological outcome?

    Barbara Castelnuovo, Helen Byakwaga, Joris Petra Schaefer, Moses Kamya and Robert Colebunders

    2007

  • Predictors of long-term viral failure among Ugandan children and adults treated with ART and monitored using clinical and immunologic criteria

    Moses R. Kamy, Harriet Mayanja-Kizza, Andrew Kambugu2, Sabrina Bakeera-Kitaka, Fred Semitala, Patricia Mwebaze-Songa, Barbara Castelnuovo, Petra Schaefer, Lisa A. Spacek, Anne Gasasira, Elly Katabira, Robert Colebunders, Thomas C Quinn, Allan Ronald, David L. Thomas, Adeodata Kekitiinwa and the Academic Alliance for AIDS Care and Prevention in Africa

    2007

  • Evaluation of clinical and laboratory parameters to predict viral response to Antiretroviral Therapy in Uganda

    Hilda Tibenderana, David Meya, Laurence John, Lisa Spacek, Irene Namugga, Stephen Magero, Thomas Quinn, Robert Colebunders, Andrew Kambugu, Steven Reynolds

    2007

  • Mean Corpuscular Volume (MCV) and Adherence to Antiretroviral Therapy in Sub-Saharan Africa

    Moorine Sekadde, Andrew Kambugu, Alan Ronald, Harriet Mayanja, David Gwatudde, Petra Schaefer, David Thomas, Moses Kamya, Walter Schlech

    2006

  • Filter Paper Transfer of Whole Blood Spot Specimens may be Reliable for Virological Monitoring of Africans on Antitretroviral Therapy

    Laura Waters, David Bisagaya Meya, Irene Namugga,Laurence John, Margaret Nabankema, Thomas Charles Quinn, Brian Gazzard, Steven J. Reynolds, Mark Nelson, Andrew Kambugu

    2006

  • Effects of antiretroviral therapy on bone age in perinatally-infected HIV-positive adolescents in sub-Saharan Africa

    Kisembo H., Bakeera-Kitaka S., Zollinger L., Snider C., Kekitiinwa A., Maganda A., Foster C., McKellar M

    2006

  • Very low CD4 T cell counts and low total lymphocyte counts at initiation of HAART are associated with a poor outcome in the first 6 months of antiretroviral treatment

    Harriet Mayanja

    2006

  • Cryptoccocal Meningitis a common cause of mortality among AIDS patients initiated on HAART

    Harriet Mayanja

    2006

  • Viral load monitoring is critical to assess early paediatric response to highly active antiretroviral therapy in a resource limited setting: The Ugandan experience

    Addy Kekitiinwa

    2006

  • Unmasking of mycobacteria tuberculosis in patients initiating free ARVs in an urban HIV clinic in Kampala Uganda

    Wandera B., Kigonya C., Kambugu A., Thomas D., Kamya M.R.

    2006

  • The early unmasking (within 30 days) of Tuberculosis (TB) in HIV infected Ugandans starting antiretroviral therapy (ART) – a review of 16 cases

    Kalimugogo.P, Baalwa.J, S.Kaliba, E.Nabankema, E.Nalintya, R.Kyeyune, F.Sewankambo, L.John, R.Colebunders, A.Kambugu

    2006

  • Response of Pruritic Papular Eruption (PPE) to highly active antiretroviral therapy (HAART) may represent a clinical marker of virological outcome.

    Barbara Castelnuovo, Helen Byakwaga, Petra Schaefer, Moses Kamya and Robert Colebunders

    2006

  • : CD38 Expression on CD8 T cells with or without other markers (HLA DR and CD45RA) is not adequate to predict the virological response to antiretroviral therapy (ART) in Ugandans.

    Michael Eller, Fred Lutwama, Laurence John, Hasan Shihab, Jennifer Serwanga, Benson Ouma, Nelson Modi, Lisa Spacek, Merlin Robb, Tom Quinn, Keith McAdam, Brian Gazzard, Peter Kelleher, Moses Kamya, and Harriett Mayanja

    2006

  • Nucleoside-associated lactic acidosis in HIV-1 infected African patients

    Mwebaze P.S., Castelnuovo B., Byakwaga H., John L., Basenero A., Ocama P., Colebunders R., Katabira E., Thomas D., Kamya M., Kambugu A

    2006

  • Comparison of two manual bead-based assays (Dyanbeads and Cytospheres) to FACS count at a public, urban clinic in Kampala, Uganda

    Lutwama F, Shihab H, Serwadda R, Kamya M, Mayanja H, Quinn T, Ronald A, Spacek L

    2006

  • The Dual Importance of Immunologic and Virologic Monitoring of Antiretroviral Therapy in Resource-limited Settings

    Moses R. Kamya, Andrew Kambugu, Fred Semitala, Patricia Mwebaze, Barbara Castelnuovo, Petra Schaefer, Julia Martin, David Guwatudde, Elly Katabira, Robert Colebunders, Allan Ronald, Dave Thomas, Harriet Mayanja

    2006

  • A prospective study of HIV-infected adolescents: monitoring growth, development and recovery while on antiretroviral therapy

    Sabrina Bakeera-Kitaka , Mehri McKellar, Elsabe du Pleissis, Theresa Piloya, Cynthia Snider, Addy Kekitiinwa , Philippa Musoke, Merle Sande, Andy Pavia

    2006

  • Second line lopinavir/ritonavir containing therapy is effective without major side effects after failing first line NNRTI containing regimens: 12 months follow up study at Mulago Hospital Adult Infectious Diseases Clinic (AIDC)

    Castelnuovo Barbara, Lutwama Fred, Mwebaze Patricia, Kambugu Andrew ; Kamya Moses

    2006

  • Trimethoprim-Sulfamethoxazole prophylaxis in HIV and malaria co-infection in Kampala

    Hakim Sendagire, Kironde, Swedberg, Musoke

    2006

  • Divine healing as a factor for non adherence to HAART at the Infectious Diseases Institute, Kampala, Uganda

    Wandera; Kigonya; Wandera,Ronal; Kamya

    2006

  • Early Success of Antiretroviral Therapy in a sub-Saharan African Cohort

    Fred Semitala, Andrew Kambugu, Elly Katabira, Harriet Mayanja, Allan Ronald, Patricia Mwebaze, Julia Martin, Petra shaefer, Dave Thomas, Moses Kamya

    2006

  • Successful ARV Roll-out : Nurse practitioner

    Nalubowa, Jackie

    2006

  • Empowering nurses in Africa in management of patients on antiretroviral therapy. Infectious Diseases Institute experience, Kampala, Uganda

    Ruth Kulume- Okwanga, Katwere Michael, Charles Steinburg

    2006

  • The evolution of patient knowledge on the cause and transmission of HIV after one year of highly active anti-retroviral therapy (HAART)

    Wanyama J, Lutwama F, Kikaawa C, Wandera B, Castelnouvo B ,Kambugu A, Kamya M

    2005

  • Rapid Decline In CD8 T Cell Activation In HIV Infected Ugandans Taking Antiretroviral Therapy Towards That of Healthy Europeans

    L.John, H.Shihab, F.Lutwama, J.Serwanga, M.Eller, P.Nabunya, K.McAdam, B.Gazzard, A.Pasterfield, P.Kelleher, M.Kamya, T.Quinn, L.Spacek, H.Mayanja

    2005

  • Evaluation of a low-cost method, the Guava EasyCD4 assay, to enumerate CD4 positive lymphocyte counts in Maryland, USA and Kampala, Uganda

    Shihab HM, Lutwama F, Summerton J, Mayanja-Kizza H, Ronald A, Kamya M, Margolick JB

    2005

  • Routine Cryptococcal Antigen(CRAG) Screening in AIDS Patients on HAART at the Infectious Diseases Institute, Kampala, Uganda

    C.N Kigonya, M.R Kamya, A. Kambugu, F.C Semitala, P.M Songa

    2005

  • Assessment of clinical training at the Infectious Disease Institute

    M Weaver, C Nakitto, G Schneider,M Kamya, R Nganwa,K McAdams, M. Sande

    2005

  • Counseling model for initiation of antiretroviral therapy: The Infectious Diseases Institute Model

    Caleb Twijukye, P. Nabongo, F. Mayanja, D. Okello, F. Sebuuma, D. Kasibante, E. Nabankema, R. Colebunders

    2005

  • Reasons for switching therapy for patients not failing first line antiretroviral therapy in the infectious diseases institute –Kampala

    Katwere.M, Tibenderana.H, Nabankema.E, Castelnuovo.B, Basenero.A, Mwebaze.P

    2005

  • Evaluation of heat denatured HIV-1 p24 antigen as an inexpensive marker for HIV-1 viral load in non-B Subtypes in Kampala, Uganda

    Fred Lutwama, Hasan M. Shihab, Jean Summerton, Harriet Mayanja, Moses R. Kamya, Thomas C. Quinn, Lisa A. Spacek

    2005

  • A study of clinical presentation and aetiologies of headache among HIV seropositive patients of the infectious diseases clinic- the basis for developing a resource constrained clinical algorithm

    Andrew Kambugu, Michael Katwere, Theresa Piloya, Matthew Wong, Allan Ronald, Bob Colebunders, Merle Sande, Elly Katabira

    2005

  • “Access to Highly Active Anti Retroviral Therapy (HAART) in Uganda: Experiences and challenges at the Adult Infectious Diseases Clinic (IDC), Mulago Hospital, Kampala, Uganda

    A.M Muganzi, C.Twijukye, A.Kambugu, D.Thomas and J.Waldron

    2005

  • Treatment Outcomes for Antiretroviral Therapy in Uganda

    Kamya,Moses

    2004

  • Improvement of Psoriatic lesions after starting Chloroquine in 3 African HIV positive patients

    HM Shihab, JJ Feld, C Liechty, FLutwama, T Piloya, F Waidha, R Colebunders

    2004

  • Health beliefs and behaviors of HIV infected people treated with antiretroviral therapy in a resource-limited setting of Kampala, Uganda

    HM Shihab, LA Spacek, D Mwesigire, A Ronald, TC Quinn, MR Kamya

    2004

  • Total lymphocyte count of 1200 cells/mm3 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda

    F C Semitala, M R Kamya, D Guwatudde, C Q Thomas, A Ronald, H K Mayanja, E T Katabira, L A Spacek

    2004

  • Treatment Outcomes at the Mulago Hospital AIDS in Kampala, Uganda: A Resource-Limited Setting

    LA Spacek, D Mwesigire, H Shihab, M McKellar, A Ronald, MR Kamya, TC Quinn

    2004

  • Training Medical Officers in Africa towards capacity building for provision of expanded Anti retroviral treatment

    H Mayanja-Kizza, C K Nakitto, M R Kamya, J Martins, P Musoke, E K Mbidde

    2004

  • Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda

    F C Semitala1, M R Kamya2, D Guwatudde2, C Q Thomas3, A Ronald4, H K Mayanja2, E T Katabira2

    2003